Document:

Pledge and Security Agreement

 Exhibit 10.2 
 EXECUTION COPY 
 PLEDGE AND SECURITY AGREEMENT 

dated as of March 17, 2011 
 by and among 
 K-V PHARMACEUTICAL COMPANY, 

EACH OF THE GRANTORS PARTY HERETO 
 and 
 WILMINGTON TRUST FSB, 

as Collateral Agent 

 TABLE OF CONTENTS 

 
  

							
	 	  	 	  	PAGE	 
	 SECTION 1.       DEFINITIONS; GRANT OF SECURITY
	  	 	1	  
	 1.1
	  	General Definitions	  	 	1	  
	 1.2
	  	Definitions; Interpretation	  	 	6	  
		
	 SECTION 2.      GRANT OF SECURITY
	  	 	7	  
	 2.1
	  	Grant of Security	  	 	7	  
	 2.2
	  	Certain Limited Exclusions	  	 	8	  
		
	 SECTION 3.      SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE
	  	 	9	  
	 3.1
	  	Security for Obligations	  	 	9	  
	 3.2
	  	Continuing Liability Under Collateral	  	 	9	  
		
	 SECTION 4.       CERTAIN PERFECTION REQUIREMENTS
	  	 	9	  
	 4.1
	  	Delivery Requirements	  	 	9	  
	 4.2
	  	Control Requirements	  	 	10	  
	 4.3
	  	Intellectual Property Recording Requirements	  	 	11	  
	 4.4
	  	Other Actions	  	 	11	  
		
	 SECTION 5.       REPRESENTATIONS AND WARRANTIES
	  	 	12	  
	 5.1
	  	Grantor Information & Status	  	 	12	  
	 5.2
	  	Collateral Identification, Special Collateral	  	 	12	  
	 5.3
	  	Ownership of Collateral and Absence of Other Liens	  	 	13	  
	 5.4
	  	Status of Security Interest	  	 	13	  
	 5.5
	  	Goods & Receivables	  	 	14	  
	 5.6
	  	Pledged Equity Interests, Investment Related Property	  	 	14	  
	 5.7
	  	Intellectual Property	  	 	14	  
	 5.8
	  	Secured Obligations	  	 	15	  
		
	 SECTION 6.       COVENANTS AND AGREEMENTS
	  	 	16	  
	 6.1
	  	Grantor Information and Status	  	 	16	  
	 6.2
	  	Collateral Identification; Special Collateral	  	 	16	  
	 6.3
	  	Impairment of Collateral	  	 	16	  
	 6.4
	  	Status of Security Interest	  	 	16	  
	 6.5
	  	Goods and Receivables	  	 	16	  
	 6.6
	  	Pledged Equity Interests, Investment Related Property	  	 	17	  
	 6.7
	  	Intellectual Property	  	 	18	  
	 6.8
	  	Insurance	  	 	20	  
		
	 SECTION 7.       FURTHER ASSURANCES; ADDITIONAL GRANTORS
	  	 	20	  
	 7.1
	  	Further Assurances	  	 	20	  
	 7.2
	  	Additional Grantors	  	 	21	  
		
	 SECTION 8.       CONCERNING THE COLLATERAL AGENT
	  	 	21	  
	 8.1
	  	Power of Attorney	  	 	21	  
	 8.2
	  	Duties of the Collateral Agent	  	 	22	  
	 8.3
	  	Rights of the Collateral Agent	  	 	23	  
	 8.4
	  	Individual Rights of Collateral Agent	  	 	24	  

  
 i 

							
	 8.5
	  	Collateral Agent’s Disclaimer	  	 	24	  
	 8.6
	  	Replacement of Collateral Agent	  	 	25	  
	 8.7
	  	Successor Collateral Agent by Merger, Etc.	  	 	25	  
	 8.8
	  	Eligibility	  	 	26	  
	 8.9
	  	Co-Collateral Agent; Separate Collateral Agent	  	 	26	  
	 8.10
	  	Liability; Enforcement Expenses; Indemnification	  	 	26	  
		
	 SECTION 9.       REMEDIES
	  	 	27	  
	 9.1
	  	Generally	  	 	27	  
	 9.2
	  	Application of Proceeds	  	 	28	  
	 9.3
	  	[Reserved]	  	 	28	  
	 9.4
	  	Investment Related Property	  	 	28	  
	 9.5
	  	Intellectual Property License	  	 	29	  
	 9.6
	  	Intellectual Property	  	 	29	  
	 9.7
	  	Cash Proceeds; Deposit Account and Controlled Accounts	  	 	31	  
		
	 SECTION 10.     COLLATERAL AGENT
	  	 	31	  
		
	 SECTION 11.     CONTINUING SECURITY INTEREST; TRANSFER OF NOTES
	  	 	32	  
		
	 SECTION 12.     [RESERVED]
	  	 	32	  
		
	 SECTION 13.     MISCELLANEOUS
	  	 	32	  
		
	 SECTION 14.     CONFLICTS
	  	 	33	  
		
	 SCHEDULE 5.1 — GENERAL INFORMATION
	  			
		
	 SCHEDULE 5.2 — COLLATERAL IDENTIFICATION
	  			
		
	 SCHEDULE 5.4 — FINANCING STATEMENTS
	  			
		
	 SCHEDULE 5.5 — LOCATION OF EQUIPMENT AND INVENTORY
	  			
		
	 SCHEDULE 5.7 — INTELLECTUAL PROPERTY – NON-INFRINGEMENT
	  			
		
	 EXHIBIT A — PLEDGE SUPPLEMENT
	  			
		
	 EXHIBIT B — UNCERTIFICATED SECURITIES CONTROL AGREEMENT
	  			
		
	 EXHIBIT C – PATENT SECURITY AGREEMENT
	  			
		
	 EXHIBIT D – TRADEMARK SECURITY AGREEMENT
	  			
		
	 EXHIBIT E – COPYRIGHT SECURITY AGREEMENT
	  			

  
 ii 

 This PLEDGE AND SECURITY AGREEMENT, dated as of March 17, 2011 (as it may be
amended, restated, supplemented or otherwise modified from time to time, this “Agreement”), among K-V PHARMACEUTICAL COMPANY, a Delaware corporation (the “Company”), certain Subsidiaries of the Company party
hereto from time to time, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (together with the Company, each, a “Grantor,” and collectively, the “Grantors”), and WILMINGTON
TRUST FSB, as collateral agent for the Secured Parties (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”). 

RECITALS: 

WHEREAS, capitalized terms used in these Recitals shall have the respective meanings set forth for such terms in Section 1.1
hereof; 
 WHEREAS, the Company has issued $225,000,000 in aggregate principal amount of the 12% Senior Secured Notes due
2015 (the “Notes”) pursuant to the indenture dated as of the date hereof (as it may be amended, restated, supplemented or otherwise modified from time to time, the “Indenture”) by and among the Company, the Grantors
and Wilmington Trust FSB, as trustee (in such capacity as trustee, together with its successors and permitted assigns in such capacity, the “Trustee”); 
 WHEREAS, to induce the purchasers of the Notes to purchase the Notes, each Grantor has agreed to secure the Obligations of each such Grantor under the Indenture and the Notes; 

WHEREAS, the parties hereto desire to more fully set forth their respective rights in connection with such security interest as
set forth herein; and 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants
herein contained, and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, each Grantor and the Collateral Agent agree as follows: 
 SECTION 1. DEFINITIONS; GRANT OF SECURITY. 
 1.1 General
Definitions. In this Agreement, the following terms shall have the following meanings: 

“Account” shall mean any “account” as such term is defined in the UCC, and in any event shall
include but shall not be limited to, all rights to payment of any monetary obligation, whether or not earned by performance, (i) for property that has been or is to be sold, leased, licensed, assigned or otherwise disposed of or (ii) for
services rendered or to be rendered. Without limiting the foregoing, the term “account” shall include all Health-Care-Insurance Receivables. 
 “Additional Grantors” shall have the meaning assigned in Section 7.2. 
 “Agreement” shall have the meaning set forth in the preamble. 
 “ANDA” shall mean an abbreviated new drug application. 
 “Cash Proceeds” shall have the meaning assigned in Section 9.7. 

  
 1 

 “Chattel Paper” shall mean “chattel paper” as
such term is defined in the UCC. Without limiting the foregoing, the term “Chattel Paper” shall in any event include all Tangible Chattel Paper and all Electronic Chattel Paper. 

“Collateral” shall have the meaning assigned in Section 2.1. 

“Collateral Agent” shall have the meaning set forth in the preamble. 

“Collateral Records” shall mean books, records, ledger cards, files, correspondence, customer lists,
supplier lists, blueprints, technical specifications, manuals, computer software and related documentation, computer printouts, tapes, disks and other electronic storage media and related data processing software and similar items that at any time
evidence or contain information relating to any of the Collateral or are otherwise necessary or helpful in the collection thereof or realization thereupon. 
 “Collateral Support” shall mean all property (real or personal) assigned, hypothecated or otherwise securing any Collateral and shall include any security agreement or other agreement
granting a Lien or security interest in such real or personal property. 
 “Company” shall have
the meaning set forth in the preamble. 
 “Contracts” shall mean (i) all contracts,
agreements, licenses and covenants between any Grantor and one or more additional parties (including but not limited to purchase orders) and (ii) any NDA and ANDA. 

“Contract Rights” shall mean all rights of any Grantor under each Contract, including, without
limitation, (i) any and all rights to receive and demand payments under any or all Contracts, (ii) any and all rights to receive and compel performance under any or all Contracts and (iii) any and all other rights, interests and
claims now existing or in the future arising in connection with any or all Contracts. 

“Control” shall mean: (1) with respect to any Deposit Accounts, control within the meaning of
Section 9-104 of the UCC, (2) with respect to any Securities Accounts, Security Entitlements, Commodity Contract or Commodity Account, control within the meaning of Section 9-106 of the UCC, (3) with respect to any Uncertificated
Securities, control within the meaning of Section 8-106 of the UCC, (4) with respect to any Certificated Security, control within the meaning of Section 8-106 of the UCC, (5) with respect to any Electronic Chattel Paper, control
within the meaning of Section 9-105 of the UCC, (6) with respect to Letter of Credit Rights, control within the meaning of Section 9-107 of the UCC and (7) with respect to any “transferable record” (as that term is
defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction), control within the meaning of
Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in the jurisdiction relevant to such transferable record. 

“Copyright Licenses” shall mean any and all Contracts providing for the granting of any right in or to
any Copyright or otherwise providing for a covenant not to sue for infringement or other violation of any Copyright (whether such Grantor is licensee or licensor thereunder), including, without limitation, the agreements required to be set forth on
Schedule 5.2(II) under the heading “Copyright Licenses”. 
 “Copyrights” shall mean
all United States, and foreign copyrights (whether or not the underlying works of authorship have been published), including but not limited to copyrights in software and all rights in and to databases, all designs (including but not limited to
industrial designs, Protected 

  
 2 

 
Designs within the meaning of 17 U.S.C. 1301 et. Seq. and Community designs), and all Mask Works (as defined under 17 U.S.C. 901 of the U.S. Copyright Act), whether registered or unregistered, as
well as all reversionary interests, and termination rights, and, with respect to any and all of the foregoing: (i) all registrations and applications therefor including, without limitation, the registrations and applications required to be
listed in Schedule 5.2(II) under the heading “Copyrights”, (ii) all extensions and renewals thereof, and (iii) all other rights of any kind accruing thereunder throughout the world. 

“Domain Names” shall mean all internet domain names and associated URL addresses in or to which any
Grantor now or hereafter has any right, title or interest. 
 “Equipment” shall mean any
“equipment” as such term is defined in the UCC, and in any event, shall include, but shall not be limited to, all machinery, equipment, furnishings, fixtures and vehicles now or hereafter owned by any Grantor and any and all additions,
substitutions and replacements of any of the foregoing and all accessions thereto, wherever located, together with all attachments, components, parts, equipment and accessories installed thereon or affixed thereto. 

“Excluded Assets” shall have the meaning as specified in the Indenture. 

“First Priority” shall mean, with respect to any Lien purported to be created in any Collateral pursuant
to any Collateral Document, that such Lien is senior to all other Liens with respect to all Collateral and such Collateral is not subject to any Liens other than Permitted Liens. 

“Grantor” and “Grantors” shall have the meaning set forth in the preamble.

 “Indenture” shall have the meaning set forth in the preamble. 

“Insurance” shall mean all insurance policies covering any or all of the Collateral (regardless of
whether the Collateral Agent is the loss payee thereof). 
 “Intellectual Property” shall mean,
the collective reference to all rights relating to intellectual property, whether arising under the United States, multinational or foreign laws or otherwise, including without limitation, Copyrights, Patents, Domain Names, Trademarks, Trade
Secrets, Trade Secret Rights, and all rights under Copyright Licenses, Patent Licenses, Trademark Licenses and Trade Secret Licenses, and the right to sue or otherwise recover for any past, present and future infringement, dilution,
misappropriation, or other violation or impairment thereof, including the right to receive all Proceeds therefrom, including without limitation license fees, royalties, income, payments, claims, damages and proceeds of suit, now or hereafter due
and/or payable with respect thereto. 
 “Intellectual Property Security Agreement” shall mean
each intellectual property security agreement executed and delivered by the applicable Grantors, substantially in the form set forth in Exhibit C, Exhibit D and Exhibit E, as applicable. 

“Inventory” shall mean merchandise, inventory and goods, and all additions, substitutions and
replacements thereof and all accessions thereto, wherever located, together with all goods, supplies, incidentals, packaging materials, labels, materials and any other items used or usable in manufacturing, processing, packaging or shipping same, in
all stages of production from raw materials through work in process to finished goods, and all products and proceeds of whatever sort and wherever located any portion thereof which may be returned, rejected, reclaimed or repossessed by the
Collateral Agent from any Grantor’s customers, and shall specifically include all “inventory” as such term is defined in the UCC. 

  
 3 

 “Investment Accounts” shall mean the Securities Accounts,
Commodity Accounts and Deposit Accounts. 
 “Investment Related Property” shall mean:
(i) all “investment property” (as such term is defined in Article 9 of the UCC) and (ii) all of the following (regardless of whether classified as investment property under the UCC): all Pledged Equity Interests, Pledged Debt,
the Investment Accounts and certificates of deposit. 
 “Material Intellectual Property” shall
mean any Intellectual Property included in the Collateral that the Company has determined in its reasonable business judgment is material to the business of the Company and its Subsidiaries, taken as a whole. 

“NDA” shall mean a new drug application. 

“Notes” shall have the meaning set forth in the preamble. 

“Patent Licenses” shall mean all Contracts providing for the granting of any right in or to any Patent or
otherwise providing for a covenant not to sue for infringement or other violation of any Patent (whether such Grantor is licensee or licensor thereunder), including, without limitation, the agreements required to be set forth on Schedule 5.2(II)
under the heading “Patent Licenses”. 
 “Patents” shall mean all United States and
foreign patents and certificates of invention, or similar industrial property rights, and applications for any of the foregoing, including, without limitation: (i) each patent and patent application required to be listed in Schedule 5.2(II)
under the heading “Patents”, (ii) all reissues, divisionals, continuations, continuations-in-part, extensions, renewals, and reexaminations thereof, and (iii) all other rights of any kind accruing thereunder throughout the world.

 “Permits” shall mean, to the extent permitted to be assigned by the terms thereof or by
applicable law, all licenses, permits, rights, orders, variances, franchises or authorizations of or from any governmental authority or agency (including but not limited to, all ANDAs and NDAs approved by the United States Food and Drug
Administration). 
 “Pledge Supplement” shall mean any supplement to this Agreement in
substantially the form of Exhibit A. 
 “Pledged Debt” shall mean all third-party
indebtedness for borrowed money owed to such Grantor, whether or not evidenced by any Instrument, including, without limitation, all indebtedness described on Schedule 5.2(I) under the heading “Pledged Debt”, issued by the obligors named
therein, the instruments, if any, evidencing any of the foregoing, and all interest, cash, instruments and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the
foregoing. 
 “Pledged Equity Interests” shall mean all Pledged Stock, Pledged LLC Interests,
Pledged Partnership Interests and any other participation or interests in any equity or profits of any business entity including, without limitation, any trust and all management rights relating to any entity whose equity interests are included as
Pledged Equity Interests. 
 “Pledged LLC Interests” shall mean all interests in any limited
liability company (except MECW) and each series thereof including, without limitation, all limited liability company interests listed on Schedule 5.2(I) under the heading “Pledged LLC Interests” and the certificates, if any,

  
 4 

 
representing such limited liability company interests and any interest of such Grantor on the books and records of such limited liability company or on the books and records of any securities
intermediary pertaining to such interest and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in
exchange for any or all of such limited liability company interests and all rights as a member of the related limited liability company other than any such interests which constitute Excluded Assets, or are otherwise excluded from the Collateral
pursuant to Section 2.2 hereof. 
 “Pledged Partnership Interests” shall mean all
interests in any general partnership, limited partnership, limited liability partnership or other partnership including, without limitation, all partnership interests listed on Schedule 5.2(I) under the heading “Pledged Partnership
Interests” and the certificates, if any, representing such partnership interests and any interest of such Grantor on the books and records of such partnership or on the books and records of any securities intermediary pertaining to such
interest and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such
partnership interests and all rights as a partner of the related partnership other than any such interests which constitute Excluded Assets, or are otherwise excluded from the Collateral pursuant to Section 2.2 hereof. 

“Pledged Stock” shall mean all shares of capital stock owned by such Grantor, including, without
limitation, all shares of capital stock described on Schedule 5.2(I) under the heading “Pledged Stock”, and the certificates, if any, representing such shares and any interest of such Grantor in the entries on the books of the
issuer of such shares or on the books of any securities intermediary pertaining to such shares, and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received,
receivable or otherwise distributed in respect of or in exchange for any or all of such shares other than any such interests which constitute Excluded Assets, or are otherwise excluded from the Collateral pursuant to Section 2.2 hereof.

 “Receivables” shall mean all rights to payment, whether or not earned by performance, for
goods or other property sold, leased, licensed, assigned or otherwise disposed of, or services rendered or to be rendered, including, without limitation all such rights constituting or evidenced by any Account, Chattel Paper, Instrument, General
Intangible, Investment Related Property or Letter of Credit Rights, together with all of Grantor’s rights, if any, in any goods or other property giving rise to such right to payment and all Collateral Support and Supporting Obligations related
thereto and all Receivables Records. 
 “Receivables Records” shall mean (i) all original
copies of all documents, instruments or other writings or electronic records or other Records evidencing the Receivables, (ii) all books, correspondence, credit or other files, Records, ledger sheets or cards, invoices, and other papers
relating to Receivables, including, without limitation, all tapes, cards, computer tapes, computer discs, computer runs, record keeping systems and other papers and documents relating to the Receivables, whether in the possession or under the
control of Grantor or any computer bureau or agent from time to time acting for Grantor or otherwise, (iii) all evidences of the filing of financing statements and the registration of other instruments in connection therewith, and amendments,
supplements or other modifications thereto, notices to other creditors, secured parties or agents thereof, and certificates, acknowledgments, or other writings, including, without limitation, Lien search reports, from filing or other registration
officers, (iv) all credit information, reports and memoranda relating thereto and (v) all other written or non-written forms of information related in any way to the foregoing or any Receivable. 

“Secured Obligations” shall have the meaning assigned in Section 3.1. 

  
 5 

 “Securities” shall mean any stock, shares, partnership
interests, voting trust certificates, certificates of interest or participation in any profit-sharing agreement or arrangement, options, warrants, bonds, debentures, notes, or other evidences of indebtedness, secured or unsecured, convertible,
subordinated or otherwise, or in general any instruments commonly known as “securities” or any certificates of interest, shares or participations in temporary or interim certificates for the purchase or acquisition of, or any right to
subscribe to, purchase or acquire, any of the foregoing. 
 “Trademark Licenses” shall mean any
and all Contracts providing for the granting of any right in or to any Trademark or otherwise providing for a covenant not to sue for infringement, dilution or other violation of any Trademark or permitting co-existence with respect to a Trademark
(whether such Grantor is licensee or licensor thereunder) , including, without limitation, the agreements required to be set forth on Schedule 5.2(II) under the heading “Trademark Licenses”. 

“Trademarks” shall mean all United States, and foreign trademarks, trade names, trade dress, corporate
names, company names, business names, fictitious business names, service marks, certification marks, collective marks, logos, other source or business identifiers and designs, whether or not registered, and with respect to any and all of the
foregoing: (i) all registrations and applications therefor including, without limitation, the registrations and applications required to be listed in Schedule 5.2(II) under the heading “Trademarks”, (ii) all extensions or
renewals of any of the foregoing, (iii) all of the goodwill of the business connected with the use of and symbolized by any of the foregoing, and (iv) all other rights of any kind accruing thereunder throughout the world. 

“Trade Secret Licenses” shall mean any and all Contracts providing for the granting of any right in or to
Trade Secrets (whether such Grantor is licensee or licensor thereunder), including, without limitation, the agreements required to be set forth on Schedule 5.2(II) under the heading “Trade Secret Licenses”. 

“Trade Secrets” shall mean all trade secrets and all other confidential or proprietary information and
know-how, whether or not the foregoing has been reduced to a writing or other tangible form, including all documents and things embodying, incorporating, or referring in any way to the foregoing, and all other similar rights of any kind accruing
thereunder throughout the world. 
 “Trade Secret Rights” shall mean the rights of any Grantor
in any Trade Secret it holds. 
 “Trustee” shall have the meaning set forth in the preamble.

 “UCC” shall mean the Uniform Commercial Code as in effect from time to time in the State of
New York; provided, however, that in the event that, by reason of mandatory provisions of law, any or all of the perfection or priority of, or remedies with respect to, any Collateral is governed by the Uniform Commercial Code as enacted and in
effect in a jurisdiction other than the State of New York, the term “UCC” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions hereof relating to such perfection,
priority or remedies. 
 “United States” shall mean the United States of America. 

1.2 Definitions; Interpretation. All capitalized terms used herein (including the preamble and recitals hereto) and not otherwise
defined herein shall have the meanings ascribed thereto in the Indenture or the UCC (as in effect on the date hereof). The incorporation by reference of terms defined in the Indenture shall survive any termination of the Indenture until this
Agreement is terminated as provided in Section 11 hereof. Any of 

  
 6 

 
the terms defined herein may, unless the context otherwise requires, be used in the singular or the plural, depending on the reference. References herein to any Section, Appendix, Schedule or
Exhibit shall be to a Section, an Appendix, a Schedule or an Exhibit, as the case may be, hereof unless otherwise specifically provided. The use herein of the word “include” or “including”, when following any general statement,
term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters, whether or not non-limiting language (such as “without
limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that fall within the broadest possible scope of such general statement,
term or matter. The terms lease and license shall include sub-lease and sub-license, as applicable. All references herein to provisions of the UCC shall include all successor provisions under any subsequent version or amendment to any Article of the
UCC. 
 SECTION 2. GRANT OF SECURITY. 
 2.1 Grant of Security. Subject to Section 2.2, each Grantor hereby grants to the Collateral Agent, for the benefit of the Secured Parties, a security interest in and continuing Lien on all of
such Grantor’s right, title and interest in, to and under all the following property interests and assets of any kind, nature or in any form whatsoever, of such Grantor, in each case whether now or hereafter existing or in which any Grantor now
has or hereafter acquires an interest and wherever the same may be located (all of which being hereinafter collectively referred to as the “Collateral”): 

(a) each and every Account; 
 (b) all cash, Cash Equivalents and Investments; 
 (c) all Chattel
Paper and promissory notes; 
 (d) all Commercial Tort Claims now or hereafter in existence, including such
claims described on Schedule 5.2(III); 
 (e) all Domain Names and Trade Secret Rights; 

(f) all Contracts, together with all Contract Rights; 

(g) all Intellectual Property; 
 (h) all Equipment; 
 (i) all Securities Accounts, Deposit Accounts
and all other demand, deposit, time, savings, cash management, passbook and similar accounts (including, without limitation, the Interest Reserve Account) maintained by, or for the benefit of, such Grantor with any person and all monies, securities,
Instruments and other investments deposited or required to be deposited in any of the foregoing; 
 (j) all
Documents; 
 (k) all General Intangibles; 

(l) all Goods; 

  
 7 

 (m) all Instruments; 

(n) all Inventory; 
 (o) all Financial Assets and Investment Related Property; 
 (p) all
Letter-of-Credit Rights (whether or not the respective letter of credit is evidenced by a writing); 
 (q) all
Permits; 
 (r) all Software and all Software licensing rights, all writings, plans, specifications and
schematics, all engineering drawings, customer lists, goodwill and licenses, and all recorded data of any kind or nature, regardless of the medium of recording; 
 (s) all Supporting Obligations; 
 (t) all intercompany claims
(including, without limitations, claims arising from the distribution by the Company of proceeds of the Notes); 

(u) all Securities and all options and warrants to purchase Securities; 

(v) all NDAs and ANDAs; 
 (w) all Insurance; 
 (x) all Receivables and Receivables Records;

 (y) all Security Entitlements in any of the foregoing; 

(z) to the extent not otherwise included above, all Collateral Records, Collateral Support and Supporting Obligations
relating to any and all of the foregoing; and 
 (aa) to the extent not otherwise included above, all Proceeds,
products, accessions, rents and profits of or in respect of any and all of the foregoing. 
 2.2 Certain Limited
Exclusions. 
 (a) Notwithstanding anything herein to the contrary, in no event will the Collateral
include and no Grantor will be deemed to have granted a security interest in (a) any of its right, title or interest in any trademark application filed on an “intent to use” basis until such time as a statement of use has been filed
with and duly accepted by the United States Patent and Trademark Office and (b) with respect to each direct or indirect foreign subsidiary of the Company (each, a “Controlled Foreign Corporation”), any assets of such Controlled
Foreign Corporation. Notwithstanding anything herein or the Indenture to the contrary, the security interest created by this Agreement shall not extend to, and the term Collateral shall not include, any Excluded Assets. 

  
 8 

 (b) For the avoidance of doubt, notwithstanding anything herein or in the
Indenture to the contrary, in no event shall the Collateral include, and no Grantor shall be deemed to have granted a security interest in, any of its right, title or interest in Makena or the Makena Agreement until such time as specified in
Section 9.04(c) of the Indenture, and then only upon compliance with the requirements specified in such Section 9.04(c). 
 (c) Notwithstanding anything herein or in the Indenture to the contrary, no Grantor shall be required to pledge or create a security interest in any Capital Stock or other equity interests of any Foreign
Subsidiary to the extent such action (i) violates applicable law (including corporate benefit, financial assistance, fraudulent preference, thin capitalization rules and similar laws or regulations which limit the ability to provide collateral
security on local assets or properties) and/or (ii) would reasonably be expected to violate or conflict with any fiduciary duties of officers or directors of such Foreign Subsidiary or result in a risk of personal or criminal liability of any
officer or director of such Foreign Subsidiary, in each case as certified to the Collateral Agent by an officer of the Issuer. 

SECTION 3. SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE. 
 3.1 Security for Obligations. This Agreement secures, and the Collateral is collateral security for, the prompt and complete payment or performance in full when due, whether at stated maturity, by
required prepayment, declaration, acceleration, demand or otherwise, of all Obligations with respect to the Securities (the “Secured Obligations”). 
 3.2 Continuing Liability Under Collateral. Notwithstanding anything herein to the contrary, (i) each Grantor shall remain liable for all obligations under the Collateral and nothing contained
herein is intended or shall be a delegation of duties to the Collateral Agent or any other Secured Party, (ii) each Grantor shall remain liable under each of the agreements included in the Collateral, including, without limitation, any
agreements relating to Pledged Partnership Interests or Pledged LLC Interests, to perform all of the obligations undertaken by it thereunder all in accordance with and pursuant to the terms and provisions thereof, (iii) neither the Collateral
Agent nor any Secured Party shall have any obligation or liability under any Collateral or under each of the agreements included in the Collateral by reason of or arising out of this Agreement or any other document related thereto nor shall the
Collateral Agent nor any Secured Party have any obligation to make any inquiry as to the nature or sufficiency of any payment received by it, have any obligation to take any action to collect or enforce any rights under any agreement included in the
Collateral, including, without limitation, any agreements relating to Pledged Partnership Interests or Pledged LLC Interests or have any obligation to verify or monitor compliance by such Grantor or other party under such agreements, and
(iv) the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from any of its duties or obligations under the contracts and agreements included in the Collateral. 

SECTION 4. CERTAIN PERFECTION REQUIREMENTS 
 4.1 Delivery Requirements 
 (a) With respect to any
Certificated Securities included in the Collateral, each Grantor shall promptly (in any case, by no later than the time otherwise required hereunder and under the Indenture) deliver to the Collateral Agent the Security Certificates evidencing such
Certificated Securities duly indorsed by an effective indorsement (within the meaning of Section 8-107 of the UCC), or 

  
 9 

 
accompanied by share transfer powers or other instruments of transfer duly endorsed by such an effective endorsement, in each case, to the Collateral Agent or in blank. 

(b) With respect to any Instruments or Tangible Chattel Paper included in the Collateral, each Grantor shall promptly (in
any case, by no later than the time otherwise required hereunder and under the Indenture) deliver to the Collateral Agent all such Instruments or Tangible Chattel Paper to the Collateral Agent duly indorsed in blank. 

4.2 Control Requirements 
 (a) With respect to any Deposit Accounts, Securities Accounts, Security Entitlements, Commodity Accounts and Commodity Contracts included in the Collateral, each Grantor shall, within the time period
specified in the Indenture for any such Investment Account, Commodity Contracts and Security Entitlement existing on the Issue Date, and within 90 days of the opening of any such Investment Account, Commodity Contracts and Security Entitlement after
the Issue Date, ensure that the Collateral Agent has Control thereof; provided that, notwithstanding the foregoing, the Company shall enter into the Interest Reserve Account Control Agreement on the Issue Date. With respect to any such Securities
Accounts or Securities Entitlements, such Control shall be accomplished by the Grantor causing the Securities Intermediary maintaining such Securities Account or Security Entitlement to enter into an agreement in substance reasonably satisfactory to
the Collateral Agent, within the time periods as specified in the preceding sentence, so that any such Securities Intermediary shall comply with the Collateral Agent’s Entitlement Orders without further consent by such Grantor. With respect to
any such Deposit Account, each Grantor shall, within the time periods specified in the first sentence of this Section 4.2(a), cause the depositary institution maintaining such account to enter into an agreement in substance reasonably
satisfactory to the Collateral Agent pursuant to which the Bank shall agree to comply with the Collateral Agent’s instructions with respect to disposition of funds in the Deposit Account without further consent by such Grantor. Notwithstanding
anything herein or in the Indenture to the contrary, the Company shall not be required to implement Control arrangements with respect to bank account xxxx-0040 at Bank of America (or any successor account), so long as such account consists
exclusively of certificates of deposit or like instruments posted as collateral in favor of the issuers of letters of credit obtained by the Company in the ordinary course of business. 

(b) With respect to any Uncertificated Security with a Fair Market Value in excess of $500,000, included in the Collateral
(other than any Uncertificated Securities credited to a Securities Account) each Grantor shall cause the issuer of such Uncertificated Security to either promptly (i) register the Collateral Agent as the registered owner thereof on the books
and records of the issuer or (ii) execute an agreement substantially in the form of Exhibit B hereto pursuant to which such issuer shall agree to comply with the Collateral Agent’s instructions with respect to disposition of funds
in the Uncertificated Security without further consent by such Grantor. 
 (c) With respect to any Letter of
Credit Rights with a Fair Market Value in excess of $500,000 included in the Collateral (other than any Letter of Credit Rights constituting a Supporting Obligation for a Receivable in which the Collateral Agent has a valid and perfected security
interest), each Grantor shall use its commercially reasonable efforts to obtain the written consent of each issuer of each related letter of credit to the assignment of the proceeds of such letter of credit to the Collateral Agent. 

(d) With respect any Electronic Chattel Paper with a Fair Market Value in excess of $500,000 or “transferable
record” (as that term is defined in Section 201 of the Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions 

  
 10 

 
Act as in effect in any relevant jurisdiction) included in the Collateral, each Grantor shall use commercially reasonable efforts to ensure that the Collateral Agent has Control thereof.

 4.3 Intellectual Property Recording Requirements 

(a) In the case of any Collateral (whether now owned or hereafter acquired) consisting of issued U.S. patents and pending
applications therefor, each Grantor shall execute and deliver to the Collateral Agent a Patent Security Agreement substantially in the form of Exhibit C hereto and, by no later than 60 days after the end of each fiscal quarter, a supplement
thereto covering all such patents and pending applications therefor (in each case, to the extent not already covered by such previous Patent Security Agreement or supplements thereto) in appropriate form for recordation with the U.S. Patent and
Trademark Office with respect to the security interest of the Collateral Agent. 
 (b) In the case of any
Collateral (whether now owned or hereafter acquired) consisting of registered U.S. federally registered trademarks and pending applications therefor, each Grantor shall execute and deliver to the Collateral Agent a Trademark Security Agreement in
substantially the form of Exhibit D hereto and, by no later than 60 days after the end of each fiscal quarter, a supplement thereto covering all such trademarks and pending applications therefor (in each case, to the extent not already
covered by such previous Trademark Security Agreement or supplements thereto) in appropriate form for recordation with the U.S. Patent and Trademark Office with respect to the security interest of the Collateral Agent. 

(c) In the case of any Collateral (whether now owned or hereafter acquired) consisting of registered U.S. copyright
registrations and exclusive Copyright Licenses in respect of registered U.S. Copyrights for which any Grantor is the licensee, each Grantor shall execute and deliver to the Collateral Agent a Copyright Security Agreement in substantially the form of
Exhibit E hereto and, by no later than 60 days after the end of each fiscal quarter, a supplement thereto covering all such U.S. copyright registrations and Copyright Licenses (in each case, to the extent not already covered by such previous
Copyright Security Agreement or supplements thereto) in appropriate form for recordation with the U.S. Copyright Office with respect to the security interest of the Collateral Agent. 

4.4 Other Actions 
 (a) Subject to the Indenture and Section 2.2 hereof, if any issuer of any Pledged Equity Interest that is not otherwise an Excluded Asset is organized under a jurisdiction outside of the
United States, each Grantor shall take, within the time periods specified in Section 9.04 of the Indenture, such additional actions which are necessary (or are otherwise reasonably requested by the Collateral Agent), which may include,
without limitation, causing the issuer to register the required pledge (if any) on its books and records or making such filings or recordings, in each case as may be necessary or advisable, under the laws of such issuer’s jurisdiction to insure
the validity, perfection and priority of the security interest of the Collateral Agent. 
 (b) Subject to the
Indenture and Section 2.2 hereof, with respect to any Pledged Partnership Interests and Pledged LLC Interests included in the Collateral, if the Grantors own less than 100% of the equity interests in any issuer of such Pledged
Partnership Interests or Pledged LLC Interests, Grantors shall use their commercially reasonable efforts to obtain the consent of each other holder of partnership interests or limited liability company interests in such issuer to the security
interest of the Collateral Agent hereunder, and following the occurrence and during the continuance of an Event of Default, the transfer of such Pledged Partnership Interests and Pledged LLC Interests to the Collateral Agent or of its designee, and
to the substitution of the Collateral Agent or its designee as a partner or member with all the rights and powers related thereto. Subject to the Indenture and Section 2.2 hereof, 

  
 11 

 
each Grantor consents to the grant by each other Grantor of a Lien in all Investment Related Property to the Collateral Agent and, without limiting the generality of the foregoing, consents to
the transfer of any Pledged Partnership Interest and any Pledged LLC Interest to the Collateral Agent or its designee following the occurrence and during the continuance of an Event of Default and to the substitution of the Collateral Agent or its
designee as a partner in any partnership or as a member in any limited liability company with all the rights and powers related thereto. 

SECTION 5. REPRESENTATIONS AND WARRANTIES. 
 As of the date hereof, each Grantor hereby represents and warrants that: 
 5.1
Grantor Information & Status 
 (a) Schedule 5.1(A) and (B) sets forth under the
appropriate headings: (1) the full legal name of such Grantor, (2) all trade names or other names under which such Grantor currently conducts business, (3) the type of organization of such Grantor, (4) the jurisdiction of
organization of such Grantor, (5) its organizational identification number, if any, and (6) the jurisdiction where the chief executive office or its sole place of business is located; 

(b) except as provided on Schedule 5.1(C), it has not changed its name, jurisdiction of organization, chief
executive office or sole place of business (or principal residence if such Grantor is a natural person) or its corporate structure in any way (e.g., by merger, consolidation, change in corporate form or otherwise) and has not done business under any
other name, in each case, within the past three (3) years; 
 (c) except as provided on Schedule
5.1(D), it has not within the last three (3) years become bound (whether as a result of merger or otherwise) as debtor under a security agreement entered into by another Person, which has not heretofore been terminated; 

(d) such Grantor has been duly organized and is validly existing as an entity of the type as set forth opposite such
Grantor’s name on Schedule 5.1(A) solely under the laws of the jurisdiction as set forth opposite such Grantor’s name on Schedule 5.1(A) and remains duly existing as such. Such Grantor has not filed any certificates of
dissolution or liquidation, any certificates of domestication, transfer or continuance in any other jurisdiction; and 
 (e) no Grantor is a “transmitting utility” (as defined in Section 9-102(a)(80) of the UCC). 
 5.2 Collateral Identification, Special Collateral 
 (a)
Schedule 5.2 sets forth under the appropriate headings all of such Grantor’s: (1) Pledged Equity Interests, (2) Pledged Debt, (3) Securities Accounts, (4) Deposit Accounts, (5) Commodity Contracts and Commodity
Accounts, (6) United States registrations and issuances of and applications for Patents, Trademarks, and Copyrights owned by each Grantor (other than Intellectual Property registrations and applications owned by any Grantor that are either
(A) expired or lapsed, (B) abandoned, or (C) Intellectual Property registrations or applications that such Grantor has instructed its applicable advisor, including in-house counsel, to abandon or allow to lapse), (7) material
Copyright Licenses, Patent Licenses, Trademark Licenses and Trade Secret Licenses to which any Grantor is a party, but excluding computer software licenses and confidentiality/non-disclosure agreements, (8) Commercial Tort Claims, and
(9) Letter of Credit Rights for letters of credit; 

  
 12 

 (b) no material portion of the Collateral constitutes, or is the Proceeds
of, (1) Farm Products, (2) As-Extracted Collateral, (3) Manufactured Homes, (4) Health-Care-Insurance Receivables; (5) timber to be cut, or (6) aircraft, aircraft engines, satellites, ships or railroad rolling stock. No
material portion of the Collateral consists of motor vehicles or other goods subject to a certificate of title statute of any jurisdiction; 
 (c) all written information supplied by any Grantor with respect to the Collateral taken as a whole is accurate and complete in all material respects; and 

(d) not more than 5% of the value of all tangible personal property included in the Collateral is located in any country
other than the United States. 
 5.3 Ownership of Collateral and Absence of Other Liens 

(a) Each Grantor owns the Collateral purported to be owned by it or otherwise has the rights it purports to have in each
item of Collateral free and clear of any and all Liens, rights or claims of all other Persons other than any Permitted Liens; and 
 (b) other than any financing statements filed in favor of the Collateral Agent, no effective financing statement, fixture filing or other instrument similar in effect under any applicable law covering all
or any part of the Collateral is on file in any filing or recording office except for (x) financing statements for which duly authorized proper termination statements have been filed and (y) financing statements filed in connection with
Permitted Liens. Other than the Collateral Agent and any automatic control in favor of a Bank, Securities Intermediary or Commodity Intermediary maintaining a Deposit Account, Securities Account or Commodity Contract, no Person (other than the
Collateral Agent) is in Control of any material portion of the Collateral (other than with respect to any bank accounts of the Grantors which are not subject to the control of the Collateral Agent pursuant to the terms of the Collateral Documents or
as otherwise permitted under the Indenture). 
 5.4 Status of Security Interest 

(a) upon the filing of financing statements naming each Grantor as “debtor” and the Collateral Agent as
“secured party” and describing the Collateral as “all assets of the debtor, whether now existing or hereafter arising” in the filing offices set forth opposite such Grantor’s name on Schedule 5.4 hereof, the security
interest of the Collateral Agent in all Collateral that can be perfected by the filing of a financing statement under the UCC as in effect in such jurisdiction will constitute a valid and perfected security interest, prior to any other Lien on such
Collateral other than any Permitted Liens. Each agreement purporting to give the Collateral Agent Control over any Collateral is effective to establish the Collateral Agent’s Control of the Collateral subject thereto; 

(b) to the extent perfection or priority of the security interest therein is not subject to Article 9 of the UCC, and upon
recordation of the security interests granted pursuant to the Intellectual Property Security Agreements in the U.S. Patent and Trademark Office and the U.S. Copyright Office, the security interests granted to the Collateral Agent hereunder shall
constitute valid, perfected, First Priority Liens in the United States with respect to the Intellectual Property identified in the schedules to such Intellectual Property Security Agreements (subject to Permitted Liens); and 

(c) no authorization, consent, approval or other action by, and no notice to or filing with, any Governmental Authority or
regulatory body or any other Person is required for either (i) the pledge or grant by any Grantor of the Liens purported to be created in favor of the Collateral Agent hereunder or (ii) the exercise by Collateral Agent of any rights or
remedies in respect of any Collateral 

  
 13 

 
(whether specifically granted or created hereunder or created or provided for by applicable law), except (A) for the filings contemplated by Section 5.4(a) above or (B) as
may be required, in connection with the disposition of any Investment Related Property, by laws generally affecting the offering and sale of Securities. 
 5.5 Goods & Receivables 
 (a) each material
Receivable (i) is the legal, valid and binding obligation of the Account Debtor in respect thereof, representing an unsatisfied obligation of such Account Debtor, (ii) is enforceable in accordance with its terms, (iii) is not subject
to any credits, rights of recoupment, setoffs, defenses, taxes, counterclaims except in the Ordinary Course of Business and (iv) is in compliance in all material respects with all applicable laws, whether federal, state, local or foreign;

 (b) except as set forth in Schedule 5.5, none of the Account Debtors in respect of any material Receivable is
the government of the United States, any agency or instrumentality thereof, any state or municipality or any foreign sovereign. No Receivable requires the consent of the Account Debtor in respect thereof in connection with the security interest
hereunder, except any consent which has been obtained; 
 (c) no Goods produced by any Grantor and included in
the Collateral have been produced in violation of the requirements of the Fair Labor Standards Act, as amended, or the rules and regulations promulgated thereunder; and 

(d) all of the Equipment and Inventory included in the Collateral is located only at the locations specified in Schedule
5.5. 
 5.6 Pledged Equity Interests, Investment Related Property 

(a) such Grantor is the record and beneficial owner of the Pledged Equity Interests free of all Liens (other than
Permitted Liens), rights or claims of other Persons and there are no outstanding warrants, options or other rights to purchase, or shareholder, voting trust or similar agreements outstanding with respect to, or property that is convertible into, or
that requires the issuance or sale of, any Pledged Equity Interests; 
 (b) no consent of any Person including
any other general or limited partner, any other member of a limited liability company, any other shareholder or any other trust beneficiary is necessary in connection with the creation, perfection or priority status of the security interest (except
for any Permitted Lien) of the Collateral Agent in any Pledged Equity Interests or the exercise by the Collateral Agent of the voting or other rights provided for in this Agreement or the exercise of remedies in respect thereof except such as have
been obtained; and 
 (c) all of the Pledged LLC Interests and Pledged Partnership Interests are or represent
interests that by their terms provide that they are securities governed by the uniform commercial code of an applicable jurisdiction. 
 5.7 Intellectual Property 
 (a) except as set forth on
Schedule 5.7, no holding, decision, ruling, or judgment has been rendered in any action or proceeding before any court or administrative authority challenging the validity, enforceability, or scope of, or such Grantor’s right to register, own
or use, any Material Intellectual Property owned by or, to such Grantor’s knowledge, exclusively licensed to, such Grantor, 

  
 14 

 
and no such action or proceeding is pending or, to such Grantor’s knowledge, threatened, in each case, other than office actions or similar actions issued in the ordinary course of
prosecutions; 
 (b) all registrations, issuances and applications for Copyrights, Patents and Trademarks owned
by such Grantor identified on Schedule 5.2 are standing in the name of such Grantor, and none of the Trademarks, Patents, Copyrights or Trade Secrets owned by such Grantor has been licensed by such Grantor to any Affiliate or third party,
except as permitted under the Indenture, and any exclusive Copyright Licenses for which any Grantor is the licensee constituting Material Intellectual Property in respect of registered U.S. Copyrights have been properly recorded in the U.S.
Copyright Office; 
 (c) except as permitted by the Indenture, such Grantor has not made a previous assignment,
sale, transfer, exclusive license, or similar arrangement constituting a future assignment, sale, transfer, exclusive license or similar arrangement of any Material Intellectual Property that has not been terminated or released; 

(d) such Grantor has used commercially reasonable efforts to use (i) appropriate statutory notice of registration in
connection with its use of registered U.S. Trademarks owned or exclusively licensed to such Grantor, and (ii) appropriate notice of copyright in connection with the publication of material Copyrights owned or exclusively licensed to such
Grantor, and such Grantor has not used marking practices in connection with its use of material Patents, Trademarks or Copyrights, in each case owned or exclusively licensed to such Grantor, that would jeopardize and/or impair, in any material
respect, the value of such Intellectual Property; 
 (e) such Grantor has taken commercially reasonable efforts
to protect the confidentiality of Trade Secrets owned by such Grantor and has not disclosed any material Trade Secrets to any third party unless such third party is subject to a valid and enforceable agreement providing for the confidentiality of
the same; 
 (f) such Grantor controls the nature and quality of all products sold and all services rendered
under or in connection with all material Trademarks owned by such Grantor, in each case substantially consistent with industry standards, and has taken all commercially reasonable action to insure that all licensees of the material Trademarks owned
by such Grantor comply with such Grantor’s standards of quality; and 
 (g) except as set forth in Schedule
5.7, no settlement or consents, covenants not to sue, co-existence agreements, non-assertion assurances, or releases have been entered into by such Grantor or bind such Grantor in a manner that would reasonably be expected to adversely affect such
Grantor’s rights to own, license or use any Intellectual Property in any material respect. 
 5.8 Secured
Obligations 
 The provisions of this Agreement, together with completion of the actions specified herein and in the
Indenture, are effective to create in favor of the Collateral Agent, for the benefit of the Secured Parties, legal, valid and perfected Liens on and security interests (having the priority provided for herein (subject to Permitted Liens)) in all
right, title and interest in the Collateral, enforceable against each Grantor. 

  
 15 

 SECTION 6. COVENANTS AND AGREEMENTS. 

As long as the Secured Obligations remain outstanding (other than contingent obligations not yet due and payable) each Grantor hereby
covenants and agrees (which covenants and agreements shall survive the execution and delivery of this Agreement) that: 
 6.1
Grantor Information and Status. The Company shall promptly notify the Collateral Agent of any change in any Grantor’s name, identity, corporate structure (e.g. by merger, consolidation, change in corporate form or otherwise), sole place of
business, chief executive office, type of organization or jurisdiction of organization or establishment of any trade names and the Company shall take (and the Collateral Agent shall cooperate with the Company to the extent necessary) all actions
reasonably necessary or advisable to maintain the continuous validity, perfection and the same or better priority of the Collateral Agent’s security interest in the Collateral granted or intended to be granted and agreed to hereby, which in the
case of any merger or other change in corporate structure shall include, without limitation, executing and delivering to the Collateral Agent a completed Pledge Supplement together with all supplements to schedules thereto, promptly upon completion
of such merger or other change in corporate structure confirming the grant of the security interest hereunder. 
 6.2
Collateral Identification; Special Collateral 
 (a) in the event that it hereafter acquires any Collateral
of a type described in Section 5.2(a) hereof, it shall (i) with respect to Collateral of the type specified in Section 4.3, comply with the terms of Section 4.3 with respect thereto and (ii) with respect to other Collateral
described in Section 5.2(a) notify the Collateral Agent thereof in writing by no later than 60 days after the end of the next occurring fiscal quarter and take such actions and execute such documents at such time in order to ensure that the
Collateral Agent has a valid, perfected, First Priority security interest in such Collateral, subject to Permitted Liens. 
 (b) in the event that it hereafter acquires or has any Commercial Tort Claim in excess of $500,000 it shall promptly deliver to the Collateral Agent a completed Pledge Supplement together with all
supplements to schedules thereto, identifying such new Commercial Tort Claims. 
 6.3 Impairment of Collateral.
The applicable Grantor shall promptly notify the Collateral Agent if any material portion of the Collateral is damaged or destroyed or otherwise impaired or adversely affected. 

6.4 Status of Security Interest. Subject to the terms of the Indenture, this Agreement and the other Collateral Documents, each
Grantor shall maintain the security interest of the Collateral Agent hereunder in all material Collateral as a valid and perfected security interest, prior to any other Lien on such Collateral other than any Permitted Liens. 

6.5 Goods and Receivables 
 (a) Other than in the ordinary course of business, each such Grantor shall not deliver any Document evidencing any Equipment and Inventory to any Person other than the issuer of such Document to claim the
Goods evidenced therefor or the Collateral Agent; 

  
 16 

 (b) [Reserved]; 

(c) each Grantor shall keep all material Equipment, Inventory and any Documents evidencing any such Equipment and
Inventory in the locations specified on Schedule 5.5 unless it shall have notified the Collateral Agent in writing promptly following any change in location, by executing and delivering to the Collateral Agent a completed Pledge Supplement
together with all supplements to schedules thereto; 
 (d) each Grantor shall keep and maintain at its own cost
and expense records of the Receivables in the ordinary course of business and consistent with past practice; 

(e) other than in the ordinary course of business and following the occurrence and during the continuation of an Event of
Default, each Grantor shall not (w) grant any extension or renewal of the time of payment of any Receivable, (x) compromise or settle any dispute, claim or legal proceeding with respect to any Receivable for less than the total unpaid
balance thereof, (y) release, wholly or partially, any Person liable for the payment thereof, or (z) allow any credit or discount thereon; and 
 (f) at any time following the occurrence and during the continuation of an Event of Default, the Collateral Agent may: (i) direct, or require any Grantor to direct, the Account Debtors under any
Receivables to make payment of all amounts due or to become due to such Grantor thereunder directly to the Collateral Agent; (ii) notify, or require any Grantor to notify, each Person maintaining a lockbox or similar arrangement to which
Account Debtors under any Receivables have been directed to make payment to remit all amounts representing collections on checks and other payment items from time to time sent to or deposited in such lockbox or other arrangement directly to the
Collateral Agent; and (iii) enforce, at the expense of such Grantor, collection of any such Receivables and to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might have
done. If the Collateral Agent notifies any Grantor that it has elected to collect the Receivables in accordance with the preceding sentence, any payments of Receivables received by such Grantor shall be forthwith (and in any event within five
(5) Business Days) deposited by such Grantor in the exact form received, duly indorsed by such Grantor to the Collateral Agent as directed, and until so turned over, all amounts and proceeds (including checks and other instruments) received by
such Grantor in respect of the Receivables, any Supporting Obligation or Collateral Support shall be received in trust for the benefit of the Collateral Agent hereunder and shall be segregated from other funds of such Grantor and such Grantor shall
not adjust, settle or compromise the amount or payment of any Receivable, or release wholly or partly any Account Debtor or obligor thereof, or allow any credit or discount thereon. 

6.6 Pledged Equity Interests, Investment Related Property 

(a) except as provided in the next sentence, in the event such Grantor receives any dividends, interest or distributions
on any Pledged Equity Interest or other Investment Related Property, upon the merger, consolidation, liquidation or dissolution of any issuer of any Pledged Equity Interest or Investment Related Property, then (a) such dividends, interest or
distributions and securities or other property shall be included in the definition of Collateral without further action and (b) such Grantor shall promptly take all reasonable steps, if any, necessary or advisable to ensure the validity,
perfection, priority and, if applicable, control of the Collateral Agent over such Investment Related Property (including, without limitation, delivery thereof to the Collateral Agent) and pending any such action such Grantor shall be deemed to hold
such dividends, interest, distributions, securities or other property in trust for the benefit of the Collateral Agent and shall segregate such dividends, distributions, Securities or other property from all other property of such Grantor.
Notwithstanding the foregoing, so long as no Event of Default shall have occurred and be continuing, the Collateral Agent authorizes each Grantor to retain all 

  
 17 

 
ordinary cash dividends and distributions paid in the normal course of the business and consistent with past practice and all scheduled payments of interest; 

(b) 
 (i) So long as no Event of Default shall have occurred and be continuing, except as otherwise provided under the covenants and agreements relating to Investment Related Property in this Agreement or
elsewhere herein, each Grantor shall be entitled to exercise or refrain from exercising any and all voting and other consensual rights pertaining to the Investment Related Property or any part thereof for any purpose not inconsistent in any material
respect with the terms of this Agreement or the Indenture; it being understood, however, that neither the voting by such Grantor of any Pledged Stock for, or such Grantor’s consent to, the election of directors (or similar governing body) at a
regularly scheduled annual or other meeting of stockholders or with respect to incidental matters at any such meeting, nor such Grantor’s consent to or approval of any action otherwise permitted under this Agreement and the Indenture, shall be
deemed inconsistent with the terms of this Agreement or the Indenture within the meaning of this Section 6.6(b)(i); and 
 (ii) Upon the occurrence and during the continuation of an Event of Default: 
  

	 	(1)	all rights of each Grantor to exercise or refrain from exercising the voting and other consensual rights which it would otherwise be entitled to exercise pursuant
hereto shall cease and all such rights shall thereupon become vested in the Collateral Agent who shall thereupon have the sole right to exercise such voting and other consensual rights; and 

 

	 	(2)	in order to permit the Collateral Agent to exercise the voting and other consensual rights which it may be entitled to exercise pursuant hereto and to receive all
dividends and other distributions which it may be entitled to receive hereunder: (1) each Grantor shall promptly execute and deliver (or cause to be executed and delivered) to the Collateral Agent all proxies, dividend payment orders and other
instruments as the Collateral Agent may from time to time reasonably request and (2) each Grantor acknowledges that the Collateral Agent may utilize the power of attorney set forth in Section 8.1. 

(c) Subject to this Agreement and the Indenture, it shall not permit any issuer of any Pledged Equity Interests to merge
or consolidate unless (i) such issuer creates a security interest that is perfected by a filed financing statement (that is not effective solely under section 9-508 of the UCC) in collateral in which such new debtor has or acquires rights,
(ii) all the outstanding capital stock or other equity interests of the surviving or resulting corporation, limited liability company, partnership or other entity is, upon such merger or consolidation, pledged hereunder and no cash, securities
or other property is distributed in respect of the outstanding equity interests of any other constituent Grantor and (iii) such Grantor promptly complies with the delivery and control requirements of Section 4 hereof. 

6.7 Intellectual Property 
 (a) such Grantor shall not do any act or omit to do any act whereby any of the Material Intellectual Property may lapse, or become abandoned, canceled, dedicated to the public (other than at the end of
its statutory term), forfeited, unenforceable or otherwise impaired, or which would adversely affect the validity, grant, or enforceability of the security interest granted therein; 

(b) such Grantor shall not, with respect to any Trademarks owned by such Grantor and constituting Material Intellectual
Property cease the use of any of such Trademarks or fail to maintain 
  

  
 18 

 
the level of the quality of products sold and services rendered under any of such Trademark at a level at least substantially consistent with the quality of such products and services as of the
date hereof, and such Grantor shall take all commercially reasonable steps to insure that licensees of such Trademarks use such consistent standards of quality; 
 (c) such Grantor shall promptly notify the Collateral Agent if it knows that any item of Material Intellectual Property may become (i) abandoned or dedicated to the public or placed in the public
domain (other than at the end of such item’s statutory term), (ii) invalid or unenforceable, (iii) subject to any materially adverse determination or development regarding such Grantor’s ownership, registration or use or the
validity or enforceability of such item of Material Intellectual Property (including the institution of, or any materially adverse development with respect to, any action or proceeding in the U.S. Patent and Trademark Office, the U.S. Copyright
Office, any state registry, any foreign counterpart of the foregoing, or any court, but excluding typical day-to-day developments during the prosecution of any such Intellectual Property) or (iv) the subject of any reversion or termination
rights; 
 (d) such Grantor shall take all commercially reasonable steps, including in any proceeding before the
U.S. Patent and Trademark Office, the U.S. Copyright Office, any state registry or any foreign counterpart of the foregoing, to pursue any application and maintain any registration or issuance of each Trademark, Patent, and Copyright owned by or
exclusively licensed to such Grantor and included in the Material Intellectual Property to the extent permitted or required by the applicable license agreement; 
 (e) subject to the effect of the applicable bankruptcy laws and other laws, such Grantor shall use commercially reasonable efforts so as not to permit the inclusion in any Contract to which it hereafter
becomes a party of any provision that could or may in any way materially impair or prevent the creation of a security interest in, or the assignment of, such Grantor’s rights and interests in any property acquired under such contracts and
included in the Material Intellectual Property, except for restrictions on transferability in leases or licenses where such Grantor believes, in its reasonable judgment, that such prohibition is usual and customary in transactions of such type;

 (f) in the event that, to such Grantor’s knowledge, any Material Intellectual Property owned by or
exclusively licensed to any Grantor is infringed, misappropriated, diluted or otherwise violated by a third party, such Grantor shall promptly take all commercially reasonable actions to stop such infringement, misappropriation, dilution or other
violation and protect its rights in such Material Intellectual Property including, but not limited to, the initiation of a suit for injunctive relief and to recover damages (with respect to exclusively licensed Intellectual Property, to the extent
permitted by the terms of the applicable license agreement); 
 (g) such Grantor shall use commercially
reasonable efforts to protect the secrecy of all Trade Secrets owned by such Grantor, including, without limitation, entering into confidentiality agreements with employees and consultants and labeling and restricting access to secret information
and documents; 
 (h) such Grantor shall use commercially reasonable efforts to use (i) appropriate
statutory notice of registration in connection with its use of registered U.S. Trademarks owned or exclusively licensed to such Grantor, and (ii) appropriate notice of copyright in connection with the publication of material Copyrights owned or
exclusively licensed to such Grantor, and such Grantor shall not sue marking practices in connection with its use of material Patents, Trademarks or Copyrights, in each case owned or exclusively licensed to such Grantor, that would jeopardize and/or
impair, in any material respect, the value of such Intellectual Property; and 

  
 19 

 (i) such Grantor shall continue to collect, at its own expense, all amounts
due or to become due to such Grantor in respect of the Intellectual Property or any portion thereof. In connection with such collections, such Grantor may take (and, at the Collateral Agent’s reasonable direction, shall take) such action as
such Grantor or the Collateral Agent may deem reasonably necessary or advisable to enforce collection of such amounts. Notwithstanding the foregoing, upon the occurrence and continuation of an Event of Default, the Collateral Agent shall have the
right at any time, to notify, or require any Grantor to notify, any obligors with respect to any such amounts of the existence of the security interest created hereby. 
 6.8 Insurance 
 With respect to casualty insurance policies that, pursuant
to Section 4.9 of the Indenture, have added a loss payable clause or endorsement naming the Collateral Agent, on behalf of the Secured Parties, as the loss payee thereunder, all insurance proceeds in excess of $500,000 per claim under
such policies shall be paid to the Collateral Agent for (i) release to the Company or other applicable Grantor promptly upon their written request for application in accordance with Section 4.15(a)(iii) of the Indenture or
(ii) application as otherwise required by the Indenture (it being understood that insurance proceeds less than or equal to $500,000, if paid to the Collateral Agent, will also be paid as aforesaid). 

SECTION 7. FURTHER ASSURANCES; ADDITIONAL GRANTORS. 
 7.1 Further Assurances 
 (a) Subject to this Agreement and
the Indenture, each Grantor agrees that from time to time, at the expense of such Grantor, that it shall promptly execute and deliver all further instruments and documents, and take all further action, that may be reasonably necessary (or otherwise
reasonably requested by the Collateral Agent) in order to create and/or maintain the validity, perfection or priority of and protect any security interest granted or purported to be granted hereby or to enable the Collateral Agent to exercise and
enforce its rights and remedies hereunder with respect to any Collateral. Without limiting the generality of the foregoing, each Grantor shall: 
 (i) file such financing or continuation statements, or amendments thereto, record security interests in Intellectual Property included in the Collateral and execute and deliver such other agreements,
instruments, endorsements, powers of attorney or notices, in order to effect, reflect, perfect and preserve the security interests granted or purported to be granted hereby; 

(ii) take all actions reasonably necessary to ensure the recordation of appropriate evidence of the Liens and security
interest granted hereunder in any Intellectual Property included in the Collateral with the U.S. Patent and Trademark Office or the U.S. Copyright Office; and 
 (iii) appear in and defend (or take such other actions as the Company reasonably determines are appropriate) any action or proceeding that could reasonably be expected to materially adversely affect such
Grantor’s title to or the Collateral Agent’s security interest in all or any material part of the Collateral. 
 (b) Without limiting the foregoing, each Grantor hereby authorizes the Collateral Agent to file a Record or Records, including, without limitation, financing or continuation statements, Intellectual
Property Security Agreements and amendments and supplements to any of the foregoing, in any jurisdictions and with any filing offices as are reasonably necessary or advisable to perfect or 

  
 20 

 
otherwise protect the security interest granted to the Collateral Agent herein. Such financing statements may describe the Collateral in the same manner as described herein or may contain an
indication or description of collateral that describes such property in any other manner as is necessary to ensure the perfection of the security interest in the Collateral granted to the Collateral Agent herein, including, without limitation,
describing such property as “all assets, whether now owned or hereafter acquired, developed or created” or words of similar effect. 
 (c) Each Grantor hereby authorizes the Collateral Agent to modify this Agreement after obtaining such Grantor’s approval of or signature to such modification by amending Schedule 5.2 to include
reference to any right, title or interest in any existing Intellectual Property or any Intellectual Property acquired or developed by any Grantor after the execution hereof or to delete any reference to any right, title or interest in any
Intellectual Property in which any Grantor no longer has or claims any right, title or interest. 
 7.2 Additional Grantors.
In accordance with Section 4.24 of the Indenture, from time to time subsequent to the date hereof, additional Persons may become parties hereto as additional Grantors (each, an “Additional Grantor”), by executing a
Pledge Supplement. Upon delivery of any such Pledge Supplement to the Collateral Agent, notice of which is hereby waived by Grantors, each Additional Grantor shall be a Grantor and shall be as fully a party hereto as if such Additional Grantor were
an original signatory hereto. Each Grantor expressly agrees that its Obligations arising hereunder shall not be affected or diminished by the addition or release of any other Grantor hereunder. This Agreement shall be fully effective as to any
Grantor that is or becomes a party hereto regardless of whether any other Person becomes or fails to become or ceases to be a Grantor hereunder. 
 SECTION 8. CONCERNING THE COLLATERAL AGENT. 
 8.1 Power of Attorney.
Without limiting any of such Grantor’s obligations and duties hereunder, each Grantor hereby irrevocably appoints the Collateral Agent (such appointment being coupled with an interest) as such Grantor’s attorney-in-fact, with full
authority in the place and stead of such Grantor and in the name of such Grantor, the Collateral Agent or otherwise, from time to time (i) to prepare and file any UCC financing statements against such Grantor as debtor in accordance with the
terms of this Agreement and the Indenture, (ii) to prepare, sign, and file for recordation in any intellectual property registry, appropriate evidence of the Lien and security interest granted herein in any Intellectual Property owned by any
Grantor or exclusive Copyright Licenses in respect of U.S. registered Copyrights for which any Grantor is licensee in the name of such Grantor as debtor in accordance with the terms of this Agreement and the Indenture and (iii) upon the
occurrence and during the continuance of an Event of Default, in the Collateral Agent’s discretion to take any appropriate action and to execute any instrument that the Collateral Agent may deem reasonably necessary or advisable to accomplish
the purposes of this Agreement, including, without limitation, the following: 
 (a) to obtain and adjust
insurance required to be maintained by such Grantor or paid to the Collateral Agent pursuant to Section 4.09 of the Indenture; 
 (b) to ask for, demand, collect, sue for, recover, compound, receive and give acquittance and receipts for monies due and to become due under or in respect of any of the Collateral; 

  
 21 

 (c) to receive, endorse and collect any drafts or other instruments,
documents and chattel paper in connection with clause (b) above; 
 (d) to file any claims or take any
action or institute any proceedings that the Collateral Agent may deem necessary or desirable for the collection of any of the Collateral or otherwise to enforce the rights of the Collateral Agent with respect to any of the Collateral; 

(e) to take or cause to be taken all actions necessary to perform or comply or cause performance or compliance with the
terms of this Agreement, including, without limitation, access to pay or discharge taxes or Liens (other than Permitted Liens) levied or placed upon or threatened against the Collateral, the legality or validity thereof and the amounts necessary to
discharge the same to be determined by the Collateral Agent in its reasonable discretion, any such payments made by the Collateral Agent to become Obligations of such Grantor to the Collateral Agent, due and payable immediately without demand; and

 (f) generally to sell, transfer, lease, license, pledge, make any agreement with respect to or otherwise deal
with any of the Collateral as fully and completely as though the Collateral Agent were the absolute owner thereof for all purposes, and to do, at the Collateral Agent’s option and such Grantor’s expense, at any time or from time to time,
all acts and things that the Collateral Agent deems reasonably necessary to protect, preserve or realize upon the Collateral and the Collateral Agent’s security interest therein in order to effect the intent of this Agreement, all as fully and
effectively as such Grantor might do. 
 8.2 Duties of the Collateral Agent. 

(a) If an Event of Default has occurred and is continuing and the Collateral Agent has received written notice thereof
from a Grantor or the Trustee, the Collateral Agent may exercise such of the rights and powers vested in it by the Indenture, this Agreement and the other Collateral Documents. The permissive right of the Collateral Agent to take or refrain from
taking any actions enumerated in the Indenture, this Agreement or any other Collateral Document shall not be construed as a duty and the Collateral Agent shall not be subject to any fiduciary or other implied duties of any kind or nature to any
Secured Party, regardless of whether an Event of Default has occurred or is occurring; 
 (b) (i) the contractual
duties of the Collateral Agent shall be determined solely by the express provisions of this Agreement and the Indenture, and the Collateral Agent need perform only those contractual duties that are specifically set forth in the Indenture, this
Agreement and the other Collateral Documents and no others, and no implied covenants or obligations shall be read into the Indenture, this Agreement or the other Collateral Documents against the Collateral Agent; and (ii) in the absence of bad
faith on its part, the Collateral Agent may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon Officers’ Certificates or Opinions of Counsel furnished to the Collateral Agent.

 (c) The Collateral Agent may not be relieved from liability for its own gross negligent action, its own
grossly negligent failure to act, or its own willful misconduct, except that: 
 (i) this paragraph does not
limit the effect of paragraph (b) or (e) of this Section 8.2; 
 (ii) the Collateral Agent shall
not be liable for any error of judgment made in good faith by an officer of the Collateral Agent, unless it is proved that the Collateral Agent was grossly negligent in ascertaining the pertinent facts; and 

  
 22 

 (iii) the Collateral Agent shall not be liable with respect to any action it
takes or omits to take in good faith in accordance with a direction received by it at the direction of the Secured Parties, or for the method and place of conducting any proceeding for any remedy available to the Collateral Agent, or exercising any
trust or power conferred upon the Collateral Agent, under this Agreement or any other Collateral Document. 
 (d)
Whether or not therein expressly so provided, every provision of this Agreement or any provision of any other Collateral Document that in any way relates to the Collateral Agent is subject to paragraphs (a), (b), (c), (e) and (f) of this
Section 8.2. 
 (e) No provision of this Agreement or any other Collateral Document shall require the
Collateral Agent to expend or risk its own funds or incur any liability. 
 (f) The Collateral Agent shall not be
liable for interest on any money received by it except as the Collateral Agent may agree in writing with the Grantors. Money held in trust by the Collateral Agent need not be segregated from other funds except to the extent required by law.

 8.3 Rights of the Collateral Agent. 

(a) The Collateral Agent may conclusively rely and shall be fully protected in acting or refraining from acting on any
document believed by it to be genuine and to have been signed or presented by the proper Person. The Collateral Agent need not investigate any fact or matter stated in any such document. The Collateral Agent shall not be obligated to communicate
with or deal in any way with any Secured Party other than the Trustee. 
 (b) The Collateral Agent may act
through its attorneys and agents and shall not be responsible for the misconduct or negligence of any attorney or agent appointed with due care. 
 (c) The Collateral Agent shall not be liable for any action it takes or omits to take in good faith that it believes to be authorized or within the rights or powers conferred upon it by this Agreement or
any other Collateral Document. Whenever in the administration of the Indenture, this Agreement or any Collateral Document the Collateral Agent shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any
action hereunder, the Collateral Agent (unless other evidence be herein specifically prescribed) may, in the absence of bad faith on its part, conclusively rely upon an Officers’ Certificate. In no event shall the Collateral Agent be liable
under or in connection with the Indenture, this Agreement or other Collateral Documents for indirect, special, incidental, punitive or consequential losses or damages of any kind whatsoever, including but not limited to lost profits, whether or not
foreseeable, even if the Collateral Agent has been advised of the possibility thereof and regardless of the form of action in which such damages are sought. 
 (d) Unless otherwise specifically provided in the Indenture, this Agreement or any other Collateral Document, any demand, request, direction or notice from any Grantor shall be sufficient if evidenced by
an Officer’s Certificate. 
 (e) The Collateral Agent shall be under no obligation to exercise any of the
rights or powers vested in it by the Indenture, this Agreement or any other Collateral Document at the request or direction of any of the Secured Parties unless such Secured Parties shall have offered to the Collateral Agent security and indemnity
satisfactory to the Collateral Agent against the costs, expenses and liabilities that might be incurred by it in compliance with such request or direction. 

  
 23 

 (f) The Collateral Agent shall not be bound to make any investigation into
the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or documents, but the Collateral
Agent, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Collateral Agent shall determine to make such further inquiry or investigation, it shall be entitled to examine during
normal business hours and upon reasonable notice the books, records and premises of any Grantor, personally or by agent or attorney at the sole cost of the Grantors, and shall incur no liability or additional liability of any kind by reason of such
inquiry or investigation. 
 (g) The rights, privileges, protections and benefits given to the Collateral Agent,
including, without limitation, its rights to be indemnified, are extended to, and shall be enforceable by, the Collateral Agent in each of its capacities hereunder, and to each agent, custodian and other Persons employed to act hereunder or under
any Collateral Document. 
 (h) The Collateral Agent may request that the Grantors deliver an Officers’
Certificate setting forth the names of individuals and/or titles of officers authorized at such time to take specified actions pursuant to the Indenture, this Agreement or any other Collateral Document, which Officers’ Certificate may be signed
by any person authorized to sign an Officers’ Certificate, including any person specified as so authorized in any such certificate previously delivered and not superseded. 

(i) In connection with exercising any right or discretionary duty hereunder or under any of the Collateral Documents, the
Collateral Agent shall be entitled to rely upon the direction of the Holders of a majority in aggregate principal amount of the Securities. The Collateral Agent shall not have any liability for taking any action at the direction of such party, or
for any failure or delay of any such party to provide timely direction to the Collateral Agent. Notwithstanding any other provision of this Agreement, (i) any such direction may not conflict with any rule of law or with this Agreement and
(ii) the Collateral Agent shall not be required to take any action that it determines might involve it in liability (unless the Collateral Agent has received satisfactory indemnity or security against such liability). 

(j) The Collateral Agent shall enjoy all the same rights, protections, immunities and indemnities granted to it and to the
Trustee under the Indenture as though set forth in full herein (with any references to the Trustee therein being deemed to refer to the Collateral Agent). In performing its functions and duties solely under this Agreement, the Collateral Agent shall
act solely as the agent of the Secured Parties and does not assume, nor shall be deemed to have assumed, any obligation or relationship of trust with or for the Secured Parties. 

(k) The Collateral Agent may consult with legal counsel, independent public accountants and other experts selected by it
and shall not be liable for any action taken or omitted to be taken by it in good faith in accordance with the advice of such counsel, accountants or experts. 
 8.4 Individual Rights of Collateral Agent. 
 Notwithstanding anything to the
contrary, the Collateral Agent in its individual or any other capacity may become the owner or pledgee of Secured Obligations and may otherwise deal with any Grantor or any Affiliate of any Grantor with the same rights it would have if it were not
the Collateral Agent. 
 8.5 Collateral Agent’s Disclaimer. 

  
 24 

 The Collateral Agent shall not be responsible for and makes no representation as to the
validity or adequacy of this Agreement or any other Collateral Document, or the existence, genuineness, value or protection of any Collateral (except for the safe custody of Collateral in its possession and the accounting for proceeds of Collateral
actually received by it in accordance with the terms hereof), the legality, effectiveness or sufficiency of any Collateral Document, or the creation, perfection, priority, sufficiency or protection of any Lien on any Collateral, and it shall not be
responsible for any statement or recital in this Agreement or any other Collateral Document. 
 8.6 Replacement of Collateral
Agent. 
 (a) A resignation or removal of the Collateral Agent and appointment of a successor Collateral
Agent shall become effective only upon the successor Collateral Agent’s acceptance of appointment as provided in this Section 8.6. The Collateral Agent may resign in writing at any time by so notifying the Company and the Trustee. The
Company may remove the Collateral Agent if: 
 (i) the Collateral Agent is removed as Trustee under the
Indenture; 
 (ii) the Collateral Agent fails to comply with Section 8.2 hereof; 

(iii) the Collateral Agent is adjudged a bankrupt or an insolvent or an order for relief is entered with respect to the
Collateral Agent under the Bankruptcy Code; 
 (iv) a custodian or public officer takes charge of the Collateral
Agent or its property; or 
 (v) in the reasonable discretion of the Company, the Collateral Agent becomes
incapable of acting. 
 (b) If the Collateral Agent resigns or is removed or if a vacancy exists in the office of
the Collateral Agent for any reason, the Company shall promptly appoint a successor Collateral Agent which complies with any eligibility requirements contained in the Indenture. 

(c) If a successor Collateral Agent does not take office within 30 days after the retiring Collateral Agent resigns or is
removed, the retiring Collateral Agent, the Company or the holders of at least 10% in principal amount of the then outstanding principal amount of Secured Obligations may petition any court of competent jurisdiction for the appointment of a
successor Collateral Agent. 
 (d) A successor Collateral Agent shall deliver a written acceptance of its
appointment to the retiring Collateral Agent and to the Company. Thereupon, the resignation or removal of the retiring Collateral Agent shall become effective, and the successor Collateral Agent shall have all the rights, powers and the duties of
the Collateral Agent under this Agreement and the other Collateral Documents. The successor Collateral Agent shall mail a notice of its succession to the Trustee. The retiring Collateral Agent shall promptly transfer all property held by it as
Collateral Agent to the successor Collateral Agent. 
 (e) If Wilmington Trust FSB is removed or resigns as
Trustee and as Collateral Agent, such resignation or removal shall only become effective upon both a successor Trustee and Collateral Agent being appointed hereunder and under the Indenture. 

8.7 Successor Collateral Agent by Merger, Etc. 

  
 25 

 If the Collateral Agent consolidates, merges or converts into, or transfers
all or substantially all of its corporate trust business to, another Person, the successor Person without any further act shall be the successor Collateral Agent under this Agreement and the other Collateral Documents. 

8.8 Eligibility. 
 There shall at all times be a Collateral Agent hereunder that meets the requirements for being a trustee under the Indenture (prior to the discharge or defeasance of the Indenture). 

8.9 Co-Collateral Agent; Separate Collateral Agent. 

At any time or times, for the purpose of meeting the legal requirements of any jurisdiction in which any of the Collateral
may at the time be located, the Company and the Collateral Agent shall have the power to appoint agents and sub-agents to the extent permitted under the Indenture. 
 8.10 Liability; Enforcement Expenses; Indemnification 
 (a)
Neither the Collateral Agent nor any of its affiliates, directors, officers, agents or employees shall be liable for any action taken or not taken by it in connection herewith (i) with the consent or at the request or direction of a Secured
Party as provided herein or (ii) in the absence of its own gross negligence or willful misconduct. Neither the Collateral Agent nor any of its affiliates, directors, officers, agents or employees shall be responsible for or have any duty to
ascertain, inquire into or verify (i) any statement, warranty or representation made in connection with this Agreement; (ii) the performance or observance of any of the covenants or agreements of the Grantors; (iii) the receipt of
items required to be delivered to the Collateral Agent; or (iv) the validity, effectiveness or genuineness of this Agreement, the other Collateral Documents or any other instrument or writing furnished in connection herewith. The Collateral
Agent shall not incur any liability by acting in reliance upon any notice, consent, certificate, statement, or other writing (which may be a bank wire, telex or similar writing) reasonably believed by it to be genuine or to be signed by the proper
party or parties. The Collateral Agent shall in all cases be fully protected in acting, or in refraining from acting, under this Agreement or any other Collateral Document or any other document furnished in connection herewith or therewith in
accordance with a written direction or a request of the Grantors or Secured Parties pursuant to the terms of this Agreement or other Collateral Document. 
 (b) Each Grantor jointly and severally agrees to pay, indemnify or reimburse the Collateral Agent for all its reasonable, out-of-pocket costs and expenses incurred in collecting against such Grantor and
enforcing or preserving any rights under this Agreement and the other Collateral Documents, including, without limitation, the reasonable, out-of-pocket fees and disbursements of counsel to the Collateral Agent. 

(c) Each Grantor agrees to pay, indemnify and to hold the Collateral Agent harmless from, any and all liabilities with
respect to, or resulting from any delay in paying, any and all stamp, excise, sales or other taxes (if any) which may be payable or determined to be payable with respect to any of the Collateral or in connection with any of the transactions
contemplated by this Agreement. 
 (d) Each Grantor agrees to pay, indemnify and to hold the Collateral Agent
harmless from any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever incurred without gross negligence or willful misconduct with respect to the
execution, delivery, enforcement, performance and administration of this Agreement. 

  
 26 

 (e) The agreements in this Section shall survive (i) any resignation or
removal of the Collateral Agent hereunder or (ii) repayment of the Obligations and all other amounts payable under the Indenture, the Collateral Documents and the Securities. 
 SECTION 9. REMEDIES. 
 9.1 Generally. Subject to the provisions
of the Indenture: 
 (a) If any Event of Default shall have occurred and be continuing, the Collateral Agent may
exercise in respect of the Collateral, in addition to all other rights and remedies provided for herein or otherwise available to it at law or in equity, all the rights and remedies of the Collateral Agent on default under the UCC (whether or not
the UCC applies to the affected Collateral) to collect, enforce or satisfy any Secured Obligations then owing, whether by acceleration or otherwise, and also may pursue any of the following separately, successively or simultaneously: 

(i) require any Grantor to, and each Grantor hereby agrees that it shall at its expense and promptly upon request of the
Collateral Agent forthwith, assemble all or part of the Collateral as directed by the Collateral Agent and make it available to the Collateral Agent at a place to be designated by the Collateral Agent that is reasonably convenient to both parties;

 (ii) enter onto the property where any Collateral is located and take possession thereof with or without
judicial process; 
 (iii) prior to the disposition of the Collateral, store, process, repair or recondition the
Collateral or otherwise prepare the Collateral for disposition in any manner to the extent the Collateral Agent deems appropriate; 
 (iv) without notice except as specified below or under the UCC, sell, assign, lease, license (on an exclusive or nonexclusive basis) or otherwise dispose of the Collateral or any part thereof in one or
more parcels at public or private sale, at any of the Collateral Agent’s offices or elsewhere, for cash, on credit or for future delivery, at such time or times and at such price or prices and upon such other terms as the Collateral Agent may
deem commercially reasonable; and 
 (v) exercise voting and other consensual rights with respect to the
Investment Related Property. 
 (b) The Collateral Agent or any other Secured Party may be the purchaser of any
or all of the Collateral at any public or private (to the extent the portion of the Collateral being privately sold is of a kind that is customarily sold on a recognized market or the subject of widely distributed standard price quotations) sale in
accordance with the UCC and the Collateral Agent or any other Secured Party, shall be entitled, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale made in
accordance with the UCC, to use and apply any of the Secured Obligations as a credit on account of the purchase price for any Collateral payable by the Collateral Agent or any other Secured Party at such sale. Each purchaser at any such sale shall
hold the property sold absolutely free from any claim or right on the part of any Grantor, and each 

  
 27 

 
Grantor hereby waives (to the extent permitted by applicable law) all rights of redemption, stay and/or appraisal which it now has or may at any time in the future have under any rule of law or
statute now existing or hereafter enacted. Each Grantor agrees that, to the extent notice of sale shall be required by law, at least ten (10) days notice (or such lesser time as commercially reasonable) to such Grantor of the time and place of
any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale of Collateral regardless of notice of sale having been given. The
Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. Each Grantor
agrees that it would not be commercially unreasonable for the Collateral Agent to dispose of the Collateral or any portion thereof by using Internet sites that provide for the auction of assets of the types included in the Collateral or that have
the reasonable capability of doing so, or that match buyers and sellers of assets. Each Grantor hereby waives any claims against the Collateral Agent arising by reason of the fact that the price at which any Collateral may have been sold at such a
private sale was less than the price which might have been obtained at a public sale, even if the Collateral Agent accepts the first offer received and does not offer such Collateral to more than one offeree. If the proceeds of any sale or other
disposition of the Collateral are insufficient to pay all the Secured Obligations, Grantors shall be liable for the deficiency and the reasonable fees of any attorneys employed by the Collateral Agent to collect such deficiency. Each Grantor further
agrees that a breach of any of the covenants contained in this Section will cause irreparable injury to the Collateral Agent, that the Collateral Agent has no adequate remedy at law in respect of such breach and, as a consequence, that each and
every covenant contained in this Section shall be specifically enforceable against such Grantor, and such Grantor hereby waives and agrees not to assert any defenses against an action for specific performance of such covenants except for a defense
that no default has occurred giving rise to the Secured Obligations becoming due and payable prior to their stated maturities. Nothing in this Section shall in any way limit the rights of the Collateral Agent hereunder. 

(c) The Collateral Agent may sell the Collateral without giving any warranties as to the Collateral. The Collateral Agent
may specifically disclaim or modify any representations and warranties of title or the like. This procedure will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. 

(d) The Collateral Agent shall have no obligation to marshal any of the Collateral. 

9.2 Application of Proceeds. All proceeds received by the Collateral Agent in respect of any sale of, any collection from,
or other realization upon all or any part of the Collateral (less all the costs and expenses of the Collateral Agent in respect of such sale or collection) shall be applied in accordance with Section 6.10 of the Indenture. 

9.3 [Reserved]. 
 9.4 Investment Related Property. Subject to the provisions of this Agreement and the Indenture, each Grantor recognizes that, by reason of certain prohibitions contained in the Securities
Act and applicable state securities laws, the Collateral Agent may be compelled, with respect to any sale of all or any part of the Investment Related Property conducted without prior registration or qualification of such Investment Related Property
under the Securities Act and/or such state securities laws, to limit purchasers to those who will agree, among other things, to acquire the Investment Related Property for their own account, for investment and not 

  
 28 

 
with a view to the distribution or resale thereof (such sale, a “private sale” for purposes of this Section). Each Grantor acknowledges that such private sale may be viewed as a
“public sale” for purposes of the UCC. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable than those obtainable through a “public sale” for purposes of the Securities Act without
such restrictions (including a public offering made pursuant to a registration statement under the Securities Act) and, notwithstanding such circumstances, each Grantor agrees that any such private sale shall be deemed to have been made in a
commercially reasonable manner and that the Collateral Agent shall have no obligation to engage in public sales and no obligation to delay the sale of any Investment Related Property for the period of time necessary to permit the issuer thereof to
register it for a form of public sale requiring registration under the Securities Act or under applicable state securities laws, even if such issuer would, or should, agree to so register it. If the Collateral Agent determines to exercise its right
to sell any or all of the Investment Related Property, upon written request, each Grantor shall and shall cause each issuer of any Pledged Stock to be sold hereunder, each partnership and each limited liability company from time to time to furnish
to the Collateral Agent all such information as the Collateral Agent may request in order to determine the number and nature of interest, shares or other instruments included in the Investment Related Property which may be sold by the Collateral
Agent in exempt transactions under the Securities Act and the rules and regulations of the Securities and Exchange Commission thereunder, as the same are from time to time in effect. 

9.5 Intellectual Property License 
 Subject to the provisions of this Agreement and the Indenture, the Company (individually and on behalf of each of the Grantors) hereby grants to the Collateral Agent a non-exclusive, irrevocable,
perpetual (until terminated in accordance with this Agreement), world-wide, royalty-free license (which shall include without limitation the right to grant sublicenses) to use and exploit the Grantor’s Intellectual Property in any manner
whatsoever, including without limitation the right to make, use, sell, offer for sale, import and export products and services incorporating such Intellectual Property for the purpose of enabling the Collateral Agent, during the continuance of an
Event of Default, to exercise rights and remedies under Section 9 hereof at such time, as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies. The license granted hereunder shall be subject to pre-existing
licenses granted by the Grantors to other persons, and, with respect to Trademarks, in the event the license set forth in this Section is exercised with regard to any Trademarks, then the licensed Trademarks shall only be used in association with
goods or services of a quality and nature consistent with the quality and reputation with which such Trademarks were associated when used by Grantors prior to the exercise of the license rights set forth herein. 

9.6 Intellectual Property 
 Subject to the provisions of this Agreement and the Indenture: 

(a) Anything contained herein to the contrary notwithstanding, in addition to the other rights and remedies provided
herein, upon the occurrence of and during the continuation of an Event of Default: 
 (i) the Collateral Agent
shall have the right (but not the obligation), upon notice to the applicable Grantor, to bring suit or otherwise commence any action or proceeding in the name of any Grantor, the Collateral Agent or otherwise, in the Collateral Agent’s sole
discretion, to enforce any Intellectual Property rights of such Grantor included in the Collateral, in which event such Grantor shall, at the reasonable request of the Collateral Agent, do any and all lawful acts and execute any and all documents
required by the Collateral Agent in aid of such enforcement, and such Grantor shall promptly, upon demand, reimburse and indemnify the 

  
 29 

 
Collateral Agent as provided in Section 12 hereof in connection with the exercise of its rights under this Section 9.6, and, to the extent that the Collateral Agent shall elect not to
bring suit to enforce any Intellectual Property rights as provided in this Section 9.6, each Grantor agrees to use all commercially reasonable measures, whether by action, suit, proceeding or otherwise, to prevent the infringement,
misappropriation, dilution or other violation of any of such Grantor’s rights in the Intellectual Property included in the Collateral by others and for that purpose agrees to diligently maintain any action, suit or proceeding against any Person
so infringing, misappropriating, diluting or otherwise violating as shall be necessary to prevent such infringement, misappropriation, dilution or other violation; 

(ii) upon written demand from the Collateral Agent, each Grantor shall grant, assign, convey or otherwise transfer to the
Collateral Agent or such Collateral Agent’s designee all of such Grantor’s right, title and interest in and to any Intellectual Property included in the Collateral and shall execute and deliver to the Collateral Agent such documents as are
necessary or appropriate to carry out the intent and purposes of this Agreement; 
 (iii) each Grantor agrees
that such an assignment and/or recording shall be applied to reduce the Secured Obligations outstanding only to the extent that the Collateral Agent (or any other Secured Party) receives cash proceeds in respect of the sale of any such Intellectual
Property; 
 (iv) within five (5) Business Days after written notice from the Collateral Agent, each Grantor
shall make available to the Collateral Agent, to the extent within such Grantor’s power and authority, such personnel in such Grantor’s employ on the date of such Event of Default as the Collateral Agent may reasonably designate, by name,
title or job responsibility, to permit such Grantor to continue, directly or indirectly, to produce, advertise and sell the products and services sold or delivered by such Grantor under or in connection with any Trademarks or Trademark Licenses,
such persons to be available to perform their prior functions on the Collateral Agent’s behalf (but such Persons shall continue to be compensated by such Grantor); and 

(v) the Collateral Agent shall have the right to notify, or require each Grantor to notify, any obligors with respect to
amounts due or to become due to such Grantor in respect of any Intellectual Property of such Grantor included in the Collateral, of the existence of the security interest created herein, to direct such obligors to make payment of all such amounts
directly to the Collateral Agent, and, upon such notification and at the expense of such Grantor, to enforce collection of any such amounts and to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent
as such Grantor might have done; 
  

	 	(1)	all amounts and proceeds (including checks and other instruments) received by Grantor in respect of amounts due to such Grantor in respect of the Collateral or any
portion thereof shall be received in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such Grantor and shall be forthwith paid over or delivered to the Collateral Agent in the same form as so received
(with any necessary endorsement) to be held as cash Collateral and applied as provided by Section 9.7 hereof; and 

  

	 	(2)	Grantor shall not adjust, settle or compromise the amount or payment of any such amount or release wholly or partly any obligor with respect thereto or allow any credit
or discount thereon. 

  
 30 

 (b) If (i) an Event of Default shall have occurred and, by reason of
cure, waiver, modification, amendment or otherwise, no longer be continuing, (ii) no other Event of Default shall have occurred and be continuing, (iii) an assignment or other transfer to the Collateral Agent of any rights, title and
interests in and to any Intellectual Property of such Grantor shall have been previously made and shall have become absolute and effective, and (iv) the Secured Obligations shall not have become immediately due and payable, upon the written
request of any Grantor, the Collateral Agent shall promptly execute and deliver to such Grantor, at such Grantor’s sole cost and expense, such assignments or other transfer prepared by such Grantor as may be necessary to reassign to such
Grantor any such rights, title and interests as may have been assigned to the Collateral Agent as aforesaid, subject to any disposition thereof that may have been made by the Collateral Agent; provided, after giving effect to such reassignment, the
Collateral Agent’s security interest granted pursuant hereto, as well as all other rights and remedies of the Collateral Agent granted hereunder, shall continue to be in full force and effect; and provided further, the rights, title and
interests so reassigned shall be free and clear of any other Liens granted by or on behalf of the Collateral Agent and the Secured Parties. 
 9.7 Cash Proceeds; Deposit Account and Controlled Accounts. 

(a) Subject to the provisions of this Agreement and the Indenture: (a) If any Event of Default shall have occurred
and be continuing, in addition to the rights of the Collateral Agent specified in Section 6.5 with respect to payments of Receivables, all proceeds of any Collateral received by any Grantor consisting of cash, checks and other near-cash items
(collectively, “Cash Proceeds”) shall be held by such Grantor in trust for the Collateral Agent, segregated from other funds of such Grantor, and shall, forthwith upon receipt by such Grantor, be turned over to the Collateral Agent
in the exact form received by such Grantor (duly indorsed by such Grantor to the Collateral Agent, if required) and held by the Collateral Agent in an account set up for that purpose. If any Event of Default should have occurred and be continuing,
any Cash Proceeds received by the Collateral Agent (whether from a Grantor or otherwise) may, in the sole discretion of the Collateral Agent, be applied by the Collateral Agent (after payment of costs and expenses incurred by the Collateral Agent in
the collection of such Cash Proceeds) against the Secured Obligations then due and owing in accordance with Section 6.10 of the Indenture. 
 (b) If any Event of Default shall have occurred and be continuing, the Collateral Agent may, in the sole discretion of the Collateral Agent, apply (after payment of costs and expenses incurred by the
Collateral Agent in the collection of such Cash Proceeds) the balance from any Deposit Account or Investment Account against the Secured Obligations then due and owing in accordance with Section 6.10 of the Indenture. 

(c) Following the application of any proceeds held by the Collateral Agent in accordance with this Section 9.7 and
the termination, cure or waiver of all existing Events of Default in accordance with the terms of the Collateral Documents, any excess proceeds then held by the Collateral Agent in accordance with this Section 9.7 shall, at the request of the
Company, be returned to the applicable Deposit Account. 
 SECTION 10. COLLATERAL AGENT. 

The Collateral Agent has been appointed to act as Collateral Agent hereunder by the Securityholders. The Collateral Agent shall be
obligated, and shall have the right hereunder, to make demands, to give notices, to exercise or refrain from exercising any rights, and to take or refrain from taking any action (including, without limitation, the release or substitution of
Collateral), solely in accordance with this Agreement and the Indenture. In furtherance of the foregoing provisions of this Section 10, each Securityholder, by its acceptance of the benefits hereof, agrees that it shall have no right
individually to realize upon any of the Collateral hereunder, it being understood and agreed by such 

  
 31 

 
Secured Party that all rights and remedies hereunder may be exercised solely by the Collateral Agent for the benefit of Secured Parties in accordance with the terms of this Section. The
provisions of the Indenture relating to the Collateral Agent including, without limitation, the provisions relating to resignation or removal of the Collateral Agent and the powers and duties and immunities of the Collateral Agent are incorporated
herein by this reference and shall survive any termination of the Indenture. 
 SECTION 11. CONTINUING SECURITY INTEREST; TRANSFER OF
NOTES. 
 This Agreement shall create a continuing security interest in the Collateral and shall remain in full force and
effect until the payment in full of all Secured Obligations (other than contingent obligations not yet due and payable), be binding upon each Grantor, its successors and assigns, and inure, together with the rights and remedies of the Collateral
Agent hereunder, to the benefit of the Collateral Agent and its successors, transferees and assigns. Without limiting the generality of the foregoing, but subject to the terms of the Indenture, any Securityholder may assign or otherwise transfer any
Notes held by it to any other Person, and such other Person shall thereupon become vested with all the benefits in respect thereof granted to Securityholders herein or otherwise. Upon the payment in full of all Secured Obligations (other than
contingent obligations not yet due and payable), the security interest granted hereby shall automatically terminate hereunder and of record and all rights to the Collateral shall revert to the Grantors. Upon any such termination the Collateral Agent
shall, at the Grantors’ expense, execute and deliver to the Grantors or otherwise authorize the filing of such documents as the Grantors shall reasonably request, including financing statement amendments to evidence such termination. Upon any
disposition of property permitted by the Indenture, the Liens granted herein and/or under the other Collateral Documents shall be deemed to be automatically released and such property shall automatically revert to the applicable Grantor with no
further action on the part of any Person. The Collateral Agent shall, at the applicable Grantor’s expense, execute and deliver or otherwise authorize the filing of such documents as such Grantor shall reasonably request, in form and substance
reasonably satisfactory to the Collateral Agent, including financing statement amendments to evidence such release. 
 SECTION 12.
[RESERVED]. 
 SECTION 13. MISCELLANEOUS. 
 Any notice required or permitted to be given under this Agreement shall be given in accordance with Section 12.02 of the Indenture. No failure or delay on the part of the Collateral Agent in the
exercise of any power, right or privilege hereunder or under the Indenture shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein, nor shall any single or partial exercise of any such power,
right or privilege preclude other or further exercise thereof or of any other power, right or privilege. All rights and remedies existing under this Agreement and the other Collateral Documents are cumulative to, and not exclusive of, any rights or
remedies otherwise available. In case any provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or Obligations, or of
such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. All covenants hereunder shall be given independent effect so that if a particular action or condition is not permitted by any of such
covenants, the fact that it would be permitted by an exception to, or would otherwise be within the limitations of, another covenant shall not avoid the occurrence of a Default or an Event of Default if such action is taken or condition exists. This
Agreement shall be binding upon and inure to the benefit of the Collateral Agent and the Grantors and their respective successors and permitted assigns. No Grantor shall assign any right, duty or obligation hereunder except as permitted by the
Indenture. This Agreement, the Indenture, the Securities and the other Collateral Documents embody the entire agreement and understanding between the Grantors and the Collateral Agent and supersede all prior agreements and understandings between
such parties relating to the subject 

  
 32 

 
matter hereof and thereof. Accordingly, the Collateral Documents may not be contradicted by evidence of prior, contemporaneous or subsequent oral agreements of the parties. There are no unwritten
oral agreements between the parties. This Agreement may be executed in one or more counterparts (including by telecopy or electronic transmission, including by .pdf or similar file) and by different parties hereto in separate counterparts, each of
which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single
counterpart so that all signature pages are physically attached to the same document. 
 SECTION 14. CONFLICTS. 

In the event of any conflict or inconsistency between the provisions of this Agreement and the Indenture, the provisions of the Indenture
shall govern. 
 [Remainder of page intentionally left blank] 

  
 33 

 IN WITNESS WHEREOF, each Grantor and the Collateral Agent have caused this Agreement to be
duly executed and delivered by their respective officers thereunto duly authorized as of the date first written above. 
  

					
	K-V Pharmaceutical Company, as a Grantor
		
	By:	 	/s/ Gregory J. Divis
		 	Name:	 	Gregory J. Divis
		 	Title:	 	President and CEO

  

					
	Zeratech Technologies USA, Inc., as a Grantor
	DrugTech Corporation, as a Grantor
	FP1096, Inc., as a Grantor
	Nesher Pharmaceuticals Inc., as a Grantor
	Nesher Solutions USA, Inc., as a Grantor
	Nesher Discovery Solutions, Inc., as a Grantor
	Ther-Rx Corporation, as a Grantor
		
	By:	 	/s/ Gregory J. Divis
		 	Name:	 	Gregory J. Divis
		 	Title:	 	President

 [Signature Page to Pledge
and Security Agreement] 

 
			
	WILMINGTON TRUST FSB,
	as Collateral Agent
		
	By:	 	/s/ Jane Schweiger
		 	Authorized Signatory

 [Signature Page
to Pledge and Security Agreement]2004 Outside Directors Stock Plan

 Exhibit 10.5 
 salesforce.com, inc. 
 2004 Outside Directors Stock Plan 

(As Amended and Restated March 8, 2011) 
  

	 	1.	ESTABLISHMENT, PURPOSE AND TERM OF PLAN.

 1.1 Establishment. The salesforce.com, inc. 2004 Outside Directors Stock Plan (the
“Plan”) was established effective as of March 1, 2004, the date of its approval by the stockholders of the Company (the “Effective Date”). 

1.2 Purpose. The purpose of the Plan is to advance the interests of the Participating Company Group and its stockholders by
providing an incentive to attract, retain and reward persons performing services as Outside Directors of the Company and by motivating such persons to contribute to the growth and profitability of the Participating Company Group. The Plan seeks to
achieve this purpose by providing for Awards in the form of Options, Restricted Stock, and Restricted Stock Units. 
 1.3
Term of Plan. The Plan shall continue in effect until the earlier of its termination by the Board or the date on which all of the shares of Stock available for issuance under the Plan have been issued and all restrictions on such shares under
the terms of the Plan and the agreements evidencing Awards granted under the Plan have lapsed. However, all Awards shall be granted, if at all, within ten (10) years from the Effective Date. 

 

	 	2.	DEFINITIONS AND CONSTRUCTION. 

2.1 Definitions. Whenever used herein, the following terms shall have their respective meanings set forth below: 

(a) “Award” means any Option, Restricted Stock or Restricted Stock Unit granted under the Plan. 

(b) “Award Agreement” means a written agreement between the Company and a Participant setting forth the terms,
conditions and restrictions of the Award granted to the Participant. An Award Agreement may be an “Option Agreement,” a “Restricted Stock Agreement” or a “Restricted Stock Units Agreement.” 

(c) “Board” means the Board of Directors of the Company. If one or more Committees have been appointed by the
Board to administer the Plan, “Board” also means such Committee(s). 
 (d) “Code” means the
Internal Revenue Code of 1986, as amended, and any applicable regulations promulgated thereunder. 

 (e) “Committee” means the Compensation Committee or other committee
of the Board duly appointed to administer the Plan and having such powers as shall be specified by the Board. Unless the powers of the Committee have been specifically limited, the Committee shall have all of the powers of the Board granted herein,
including, without limitation, the power to amend or terminate the Plan at any time, subject to the terms of the Plan and any applicable limitations imposed by law. 
 (f) “Company” means salesforce.com, inc., a Delaware corporation, or any successor corporation thereto. 
 (g) “Consultant” means a person engaged to provide consulting or advisory services (other than as an Employee or a Director) to a Participating Company. 

(h) “Director” means a member of the Board or of the board of directors of any other Participating Company.

 (i) “Disability” means the permanent and total disability of the Participant within the meaning of
Section 22(e)(3) of the Code. 
 (j) “Dividend Equivalent” means a credit, made at the discretion
of the Board or as otherwise provided by the Plan, to the account of a Participant in an amount equal to the cash dividends paid on one share of Stock for each share of Stock represented by an Award held by such Participant. 

(k) “Employee” means any person treated as an employee (including an officer of the Company or a Director who is
also treated as an employee) in the records of a Participating Company; provided, however, that neither service as a Director nor payment of a director’s fee shall be sufficient to constitute employment for purposes of the Plan.

 (l) “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

(m) “Fair Market Value” means, as of any date, the value of a share of Stock or other property as determined by
the Board, in its discretion, or by the Company, in its discretion, if such determination is expressly allocated to the Company herein, subject to the following: 
 (i) If, on such date, the Stock is listed on a national or regional securities exchange or market system, the Fair Market Value of a share of Stock shall be the closing price of a share of Stock (or the
mean of the closing bid and asked prices of a share of Stock if the Stock is so quoted instead) as quoted on the New York Stock Exchange or such other national or regional securities exchange or market system constituting the primary market for
the Stock, as reported in The Wall Street Journal or such other source as the Company deems reliable. If the relevant date does not fall on a day on which the Stock has traded on such securities exchange or market system, the date on which
the Fair Market Value shall be established shall be the last day on which the Stock was so traded prior to the relevant date, or such other appropriate day as shall be determined by the Board, in its discretion. 

  
 -2-

 (ii) If, on such date, the Stock is not listed on a national or regional securities
exchange or market system, the Fair Market Value of a share of Stock shall be as determined by the Board in good faith without regard to any restriction other than a restriction which, by its terms, will never lapse. 

(n) “Inside Director” means a director who is an Employee. 

(o) “Officer” means any person designated by the Board as an officer of the Company. 

(p) “Option” means a right to purchase Stock (subject to adjustment as provided in Section 4.2) pursuant to
the terms and conditions of the Plan. Each Option shall be a nonstatutory stock option, that is an option not intended to qualify as an incentive stock option within the meaning of Section 422(b) of the Code. 

(q) “Outside Director” means a Director of the Company who is not an Employee or a Consultant. 

(r) “Outside Director Stock Award” means Stock granted to a Participant pursuant to Section 6 of the Plan.

 (s) “Parent Corporation” means any present or future “parent corporation” of the Company,
as defined in Section 424(e) of the Code. 
 (t) “Participant” means any eligible person who
has been granted one or more Awards. 
 (u) “Participating Company” means the Company or any Parent
Corporation or Subsidiary Corporation. 
 (v) “Participating Company Group” means, at any point in
time, all corporations collectively which are then Participating Companies. 
 (w) “Restriction Period”
means the period established in accordance with Section 8.2 of the Plan during which shares subject to a Restricted Stock Award are subject to Vesting Conditions. 
 (x) “Restricted Stock” means Stock granted to a Participant pursuant to Section 6 or Section 8 of the Plan. 

  
 -3-

 (y) “Restricted Stock Unit” means a bookkeeping entry representing
a right granted to a Participant pursuant to Section 9 of the Plan to receive a share of Stock on a date determined in accordance with the provisions of Section 9 and the Participant’s Award Agreement. 

(z) “Rule 16b-3” means Rule 16b-3 under the Exchange Act, as amended from time to time, or any
successor rule or regulation. 
 (aa) “Securities Act” means the Securities Act of 1933, as amended.

 (bb) “Service” means a Participant’s employment or service with the Participating Company
Group, whether in the capacity of an Employee, a Director, or a Consultant. A Participant’s Service shall not be deemed to have terminated merely because of a change in the capacity in which the Participant renders Service to the Participating
Company Group or a change in the Participating Company for which the Participant renders such Service, provided that there is no interruption or termination of the Participant’s Service. Furthermore, a Participant’s Service shall not be
deemed to have terminated if the Participant takes any military leave, sick leave, or other bona fide leave of absence approved by the Company. Notwithstanding the foregoing, unless otherwise designated by the Company or required by law, a leave of
absence shall not be treated as Service for purposes of determining vesting under a Participant’s Award Agreement. A Participant’s Service shall be deemed to have terminated either upon an actual termination of Service or upon the
corporation for which the Participant performs Service ceasing to be a Participating Company. Subject to the foregoing, the Company, in its discretion, shall determine whether a Participant’s Service has terminated and the effective date of
such termination. 
 (cc) “Stock” means the common stock of the Company, as adjusted from time to time
in accordance with Section 4.2. 
 (dd) “Subsidiary Corporation” means any present or future
“subsidiary corporation” of the Company, as defined in Section 424(f) of the Code. 
 (ee)
“Vesting Conditions” mean those conditions established in accordance with Section 8.2 or Section 9.2 of the Plan prior to the satisfaction of which shares of Restricted Stock or Restricted Stock Units remain subject
to forfeiture to the Company upon the Participant’s termination of Service. 
 2.2 Construction. Captions and titles
contained herein are for convenience only and shall not affect the meaning or interpretation of any provision of the Plan. Except when otherwise indicated by the context, the singular shall include the plural and the plural shall include the
singular. Use of the term “or” is not intended to be exclusive, unless the context clearly requires otherwise. 

  
 -4-

	 	3.	ADMINISTRATION. 

 3.1 Administration by the Board. The Plan shall be administered by the Board, including any duly appointed Committee of the Board. At any time that any class of equity security of the Company is
registered pursuant to Section 12 of the Exchange Act, the Plan shall be administered in compliance with the requirements, if any, of Rule 16b-3. All questions of interpretation of the Plan or of any Award shall be determined by the Board,
and such determinations shall be final and binding upon all persons having an interest in the Plan or such Award. 
 3.2
Authority of Officers. Any Officer shall have the authority to act on behalf of the Company with respect to any matter, right, obligation, determination or election which is the responsibility of or which is allocated to the Company herein,
provided the Officer has apparent authority with respect to such matter, right, obligation, determination or election. 
 3.3
Powers of the Board. In addition to any other powers set forth in the Plan and subject to the provisions of the Plan, the Board shall have the full and final power and authority, in its discretion: 

(a) to determine the persons to whom, and the time or times at which, Awards shall be granted and the number of shares of Stock or units
to be subject to each Award; 
 (b) to determine the type of Award granted; 

(c) to determine the Fair Market Value of shares of Stock or other property; 

(d) to determine the terms, conditions and restrictions applicable to each Award (which need not be identical) and any shares acquired
pursuant thereto, including, without limitation, (i) the exercise or purchase price of shares purchased pursuant to any Award, (ii) the method of payment for shares purchased pursuant to any Award, (iii) the method for satisfaction of
any tax withholding obligation arising in connection with Award, including by the withholding or delivery of shares of Stock, (iv) the timing, terms and conditions of the exercisability or vesting of any Award or any shares acquired pursuant
thereto, (v) the time of the expiration of any Award, (vi) the effect of the Participant’s termination of Service on any of the foregoing, and (vii) all other terms, conditions and restrictions applicable to any Award or shares
acquired pursuant thereto not inconsistent with the terms of the Plan; 
 (e) to approve one or more forms of Award Agreement;

 (f) to amend, modify, extend, cancel or renew any Award or to waive any restrictions or conditions applicable to any Award
or any shares acquired pursuant thereto; 
 (g) to accelerate, continue, extend or defer the exercisability or vesting of any
Award or any shares acquired pursuant thereto, including with respect to the period following a Participant’s termination of Service; 

  
 -5-

 (h) to prescribe, amend or rescind rules, guidelines and policies relating to the plan, or
to adopt sub-plans or supplements to, or alternative versions of, the Plan, including, without limitation, as the Board deems necessary or desirable to comply with the laws or regulations of or to accommodate the tax policy, accounting principles or
custom of, foreign jurisdictions whose citizens may be granted Awards; and 
 (i) to correct any defect, supply any omission or
reconcile any inconsistency in the Plan or any Award Agreement and to make all other determinations and take such other actions with respect to the Plan or any Award as the Board may deem advisable to the extent not inconsistent with the provisions
of the Plan or applicable law. 
 3.4 Indemnification. In addition to such other rights of indemnification as they may
have as members of the Board or officers or employees of the Participating Company Group, members of the Board and any officers or employees of the Participating Company Group to whom authority to act for the Board or the Company is delegated shall
be indemnified by the Company against all reasonable expenses, including attorneys’ fees, actually and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein, to which
they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan, or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved
by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding that such
person is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60) days after the institution of such action, suit or proceeding, such person shall offer to the Company, in writing,
the opportunity at its own expense to handle and defend the same. 
  

	 	4.	SHARES SUBJECT TO PLAN. 

4.1 Maximum Number of Shares Issuable. Subject to adjustment as provided in Section 4.2, the maximum aggregate number of
shares of Stock that may be issued under the Plan shall be one million (1,000,000) and shall consist of authorized but unissued or reacquired shares of Stock or any combination thereof. If an outstanding Award for any reason expires or is
terminated or canceled without having been exercised or settled in full, or if shares of Stock acquired pursuant to an Award subject to forfeiture or repurchase are forfeited or repurchased by the Company at the Participant’s purchase price,
the shares of Stock allocable to the terminated portion of such Award or such forfeiture or repurchased shares of Stock shall again be available for issuance under the Plan. Shares of Stock shall not be deemed to have been issued pursuant to the
Plan to the extent such shares are withheld in satisfaction of tax withholding obligations pursuant to Section 13.2. If the exercise price of an Option is paid by tender to the Company, or attestation to the ownership, of shares of Stock owned
by the Participant, the number of shares available for issuance under the Plan shall be reduced by the net number of shares for which the Option is exercised. 
 4.2 Adjustments for Changes in Capital Structure. Subject to any required action by the stockholders of the Company, in the event of any change in the Stock effected without receipt of
consideration by the Company, whether through merger, consolidation, reorganization, 

  
 -6-

 
reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock split, split-up, split-off, spin-off, combination of shares, exchange of shares, or similar change
in the capital structure of the Company, or in the event of payment of a dividend or distribution to the stockholders of the Company in a form other than Stock (excepting normal cash dividends) that has a material effect on the Fair Market Value of
shares of Stock, appropriate adjustments shall be made in the number and class of shares subject to the Plan and to any outstanding Awards, and in the exercise per share under any outstanding Award in order to prevent dilution or enlargement of
Participants’ rights under the Plan. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as “effected without receipt of consideration by the Company.” Any fractional share
resulting from an adjustment pursuant to this Section 4.2 shall be rounded down to the nearest whole number, and in no event may the exercise or purchase price under any Award be decreased to an amount less than the par value, if any, of the
stock subject to such Award. The adjustments determined by the Committee pursuant to this Section 4.2 shall be final, binding and conclusive. 
  

	 	5.	ELIGIBILITY FOR PARTICIPATION. 

Only those persons who, at the time of grant, are serving as Outside Directors shall be eligible to become Participants and to be granted
an Award. 
  

	 	6.	TERMS AND CONDITIONS OF OUTSIDE DIRECTOR STOCK
AWARDS. 

 Outside Director Stock Awards shall be evidenced by Award
Agreements specifying the number of shares of Stock covered thereby, in such form as the Board shall from time to time establish. Such Award Agreements may incorporate all or any of the terms of the Plan by reference and shall comply with and be
subject to the following terms and conditions and those terms and conditions set forth in Section 8 which are not inconsistent with the following: 
 6.1 Automatic Grant of Outside Director Stock Awards. On the fourth Tuesday of the first month of each fiscal quarter of the Company during which the Outside Director serves on the Board and
provided he or she served on the Board during any portion of the immediately preceding fiscal quarter, the Outside Director shall be granted automatically and without further action of the Board an Outside Director Stock Award consisting of 800
shares of Stock in consideration for the Participant’s service as a Director during the preceding fiscal quarter, provided that his or her Service has not terminated prior to such date (provided further, that, with respect to the Outside
Director Stock Awards granted on or after September 14, 2010 but prior to May 25, 2011, such stock awards will be in the amount of 1,500 shares ). Notwithstanding the foregoing, a Participant may elect not to receive an Outside Director
Stock Award by delivering written notice of such election to the Board no later than the day prior to the date such Outside Director Stock Award would otherwise be granted. A Participant so declining an Outside Director Stock Award shall receive no
payment or other consideration in lieu of such declined Award. A Participant who has declined an Outside Director Stock Award may revoke such election by delivering written notice of such revocation to the Board no later than the day prior to the
date such Award would be granted pursuant this Section. The Board in its discretion may change and 

  
 -7-

 
otherwise revise the terms of Outside Director Stock Awards granted under this Section 6.1, including, without limitation, the number of units subject thereto, for Outside Director Stock
Awards granted on or after the date the Board determines to make any such change or revision. 
 6.2 Purchase Price. No
monetary payment (other than applicable tax withholding, if any) shall be required as a condition of receiving an Outside Director Stock Award, the consideration for which shall be services actually rendered to the Company or for its benefit during
the preceding fiscal quarter of the Company; 
 6.3 Vesting. The shares of Stock granted pursuant to an Outside Director
Stock Award shall be fully vested on the date of grant. 
  

	 	7.	TERMS AND CONDITIONS OF OPTIONS. 

Options shall be evidenced by Award Agreements specifying the number of shares of Stock covered thereby, in such form as the Board shall
from time to time establish. No Option or purported Option shall be a valid and binding obligation of the Company unless evidenced by a fully executed Award Agreement. Award Agreements may incorporate all or any of the terms of the Plan by reference
and shall comply with and be subject to the following terms and conditions: 
 7.1 Exercise Price. The exercise price for
each Option shall be the Fair Market Value of a share of Stock on the effective date of grant of the Option. Notwithstanding the foregoing, an Option may be granted with an exercise price lower than the minimum exercise price set forth above if such
Option is granted pursuant to an assumption or substitution for another option in a manner that would qualify under the provisions of Section 424(a) of the Code. 
 7.2 Exercisability and Term of Options. Options shall be exercisable at such time or times, or upon such event or events, and subject to such terms, conditions, performance criteria and
restrictions as shall be determined by the Board and set forth in the Award Agreement evidencing such Option; provided, however, that no Option shall be exercisable after the expiration of ten (10) years after the effective date of grant of
such Option. Subject to the foregoing, unless otherwise specified by the Board in the grant of an Option, any Option granted hereunder shall terminate ten (10) years after the effective date of grant of the Option, unless earlier terminated in
accordance with its provisions. 
 7.3 Payment of Exercise Price. 

(a) Forms of Consideration Authorized. Except as otherwise provided below, payment of the exercise price for the number of
shares of Stock being purchased pursuant to any Option shall be made (i) in cash, by check or cash equivalent, (ii) by tender to the Company, or attestation to the ownership, of shares of Stock owned by the Participant having a Fair Market
Value not less than the exercise price, (iii) by delivery of a properly executed notice of exercise together with irrevocable instructions to a broker providing for the assignment to the Company of the proceeds of a sale or loan with respect to
some or all of the shares being acquired upon the exercise of the Option (including, without limitation, through an exercise complying with the provisions of 

  
 -8-

 
Regulation T as promulgated from time to time by the Board of Governors of the Federal Reserve System) (a “Cashless Exercise”), (iv) by such other consideration as
may be approved by the Board from time to time to the extent permitted by applicable law, or (v) by any combination thereof. The Board may at any time or from time to time, by approval of or by amendment to the standard forms of Award Agreement
described in Section 10, or by other means, grant Options which do not permit all of the foregoing forms of consideration to be used in payment of the exercise price or which otherwise restrict one or more forms of consideration. 

(b) Limitations on Forms of Consideration. 
 (i) Tender of Stock. Notwithstanding the foregoing, an Option may not be exercised by tender to the Company, or attestation to the ownership, of shares of Stock to the extent such tender or
attestation would constitute a violation of the provisions of any law, regulation or agreement restricting the redemption of the Company’s stock. Unless otherwise provided by the Board, an Option may not be exercised by tender to the Company,
or attestation to the ownership, of shares of Stock unless such shares either have been owned by the Participant for more than six (6) months (and not used for another Option exercise by attestation during such period) or were not
acquired, directly or indirectly, from the Company. 
 (ii) Cashless Exercise. The Company reserves, at any and all
times, the right, in the Company’s sole and absolute discretion, to establish, decline to approve or terminate any program or procedures for the exercise of Options by means of a Cashless Exercise, including with respect to one or more
Participants specified by the Company notwithstanding that such program or procedures may be available to other Participants. 

7.4 Effect of Termination of Service. 
 (a) Option Exercisability. Subject to earlier termination of the Option as otherwise provided herein and unless otherwise provided by the Board in the grant of an Option and set forth in the
Award Agreement, an Option shall be exercisable after a Participant’s termination of Service only during the applicable time period determined in accordance with this Section 7.4 and thereafter shall terminate: 

(i) Disability. If the Participant’s Service terminates because of the Disability of the Participant, the Option, to the
extent unexercised and exercisable on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal representative) at any time prior to the expiration of one
(1) year (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated, but in any event no later than the date of expiration of the Option’s term as set
forth in the Award Agreement evidencing such Option (the “Option Expiration Date”). 
 (ii)
Death. If the Participant’s Service terminates because of the death of the Participant, the Option, to the extent unexercised and exercisable on the date on which the Participant’s Service terminated, may be exercised by the
Participant’s legal representative or other person who acquired the right to exercise the Option by reason of the Participant’s death at any 

  
 -9-

 
time prior to the expiration of one (1) year (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated,
but in any event no later than the Option Expiration Date. The Participant’s Service shall be deemed to have terminated on account of death if the Participant dies within ninety (90) days (or such longer period of time as determined by the
Board, in its discretion) after the Participant’s termination of Service. 
 (iii) Termination After Change in
Control. If the Participant’s Service terminates for any reason except Disability or death upon or within one (1) year following a Change in Control (a “Termination After Change in Control”), then the Option
(unless terminated pursuant to Section 11.2), to the extent unexercised and exercisable on the date on which the Participant’s Service terminated, may be exercised by the Participant (or the Participant’s guardian or legal
representative) at any time prior to the expiration of one hundred eighty (180) days (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated, but in
any event no later than the Option Expiration Date. 
 (iv) Other Termination of Service. If the Participant’s
Service terminates for any reason, except Disability, death or Termination After Change in Control, the Option, to the extent unexercised and exercisable by the Participant on the date on which the Participant’s Service terminated, may be
exercised by the Participant at any time prior to the expiration of ninety (90) days (or such longer period of time as determined by the Board, in its discretion) after the date on which the Participant’s Service terminated, but in any
event no later than the Option Expiration Date. 
 (b) Extension if Exercise Prevented by Law. Notwithstanding the
foregoing, if the exercise of an Option within the applicable time periods set forth in Section 7.4(a) is prevented by the provisions of Section 12 below, the Option shall remain exercisable until ninety (90) days (or such longer
period of time as determined by the Board, in its discretion) after the date the Participant is notified by the Company that the Option is exercisable, but in any event no later than the Option Expiration Date. 

(c) Extension if Participant Subject to Section 16(b). Notwithstanding the foregoing, if a sale within the applicable time
periods set forth in Section 7.4(a) of shares acquired upon the exercise of the Option would subject the Participant to suit under Section 16(b) of the Exchange Act, the Option shall remain exercisable until the earliest to occur
of (i) the tenth (10th) day following the date on which a sale of such shares by the Participant would no longer be subject to such suit, (ii) the one hundred and ninetieth (190th) day after the Participant’s termination of
Service, or (iii) the Option Expiration Date. 
 7.5 Transferability of Options. During the lifetime of the
Participant, an Option shall be exercisable only by the Participant or the Participant’s guardian or legal representative. Prior to the issuance of shares of Stock upon the exercise of an Option, the Option shall not be subject in any manner to
anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the Participant’s beneficiary, except transfer by will or by the laws of descent and distribution.
Notwithstanding the foregoing, to the 

  
 -10-

 
extent permitted by the Board, in its discretion, and set forth in the Award Agreement evidencing such Option, an Option shall be assignable or transferable subject to the applicable limitations,
if any, described in the General Instructions to Form S-8 Registration Statement under the Securities Act. 
 7.6
Automatic Grant of Options. Each Outside Director who first becomes an Outside Director prior to September 14, 2010 shall be granted automatically and without further action of the Board an Option to purchase 15,000 shares of Stock on
the date on which such person first becomes an Outside Director, whether through election by the stockholders of the Company or appointment by the Board to fill a vacancy; provided, however, that an Inside Director who ceases to be an Inside
Director but who remains a Director shall not receive such Option. The Option shall become exercisable as to twenty-five percent of the shares of Stock subject to the Option on the one (1) year anniversary of its grant date and as to one
forty-eighth (1/48) of the shares of Stock subject to the Option each month thereafter, so as to be 100% vested on the four year anniversary of the grant date, provided that the Optionee continues to serve as an Outside Director on such dates.
The Board in its discretion may change and otherwise revise the terms of Options granted under this Section 7.6, including, without limitation, the number of shares of Stock and exercise prices thereof, for Options granted on or after the date
the Board determines to make any such change or revision. 
  

	 	8.	TERMS AND CONDITIONS OF RESTRICTED STOCK
AWARDS. 

 Restricted Stock Awards shall be evidenced by Award Agreements
specifying the number of shares of Stock subject to the Award, in such form as the Board shall from time to time establish. No Restricted Stock Award or purported Restricted Stock Award shall be a valid and binding obligation of the Company unless
evidenced by a fully executed Award Agreement. Award Agreements evidencing Restricted Stock may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following terms and conditions: 

8.1 Purchase Price. No monetary payment (other than applicable tax withholding, if any) shall be required as a condition of
receiving shares of Restricted Stock, the consideration for which shall be services actually rendered to a Participating Company or for its benefit. Notwithstanding the foregoing, if required by applicable law, the Participant shall furnish
consideration in the form of cash or past services rendered to a Participating Company or for its benefit having a value not less than the par value of the shares of Restricted Stock subject to such Award. 

8.2 Vesting and Restrictions on Transfer. Shares issued pursuant to any Restricted Stock Award may or may not be made subject to
Vesting Conditions based upon the satisfaction of such Service requirements, conditions, restrictions or performance criteria as shall be established by the Board and set forth in the Award Agreement evidencing such Award. During any Restriction
Period in which shares acquired pursuant to a Restricted Stock Award remain subject to Vesting Conditions, such shares may not be sold, exchanged, transferred, pledged, assigned or otherwise disposed of other than pursuant to an Ownership Change
Event, as defined in Section 11.1, or as provided in Section 8.5. Upon request by the Company, each Participant shall 

  
 -11-

 
execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Restricted Stock hereunder and shall promptly present to the Company any and all certificates
representing shares of Restricted Stock acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. 
 8.3 Voting Rights; Dividends and Distributions. Except as provided in this Section, Section 8.2 and any Award Agreement, during the Restriction Period applicable to shares subject to a
Restricted Stock Award, the Participant shall have all of the rights of a stockholder of the Company holding shares of Stock, including the right to vote such shares and to receive all dividends and other distributions paid with respect to such
shares. However, in the event of a dividend or distribution paid in shares of Stock or any other adjustment made upon a change in the capital structure of the Company as described in Section 4.2, then any and all new, substituted or additional
securities or other property (other than normal cash dividends) to which the Participant is entitled by reason of the Participant’s Restricted Stock Award shall be immediately subject to the same Vesting Conditions as the shares subject to the
Restricted Stock Award with respect to which such dividends or distributions were paid or adjustments were made. 
 8.4
Effect of Termination of Service. Unless otherwise provided by the Board in the grant of a Restricted Stock Award and set forth in the Award Agreement, if a Participant’s Service terminates for any reason, whether voluntary or
involuntary (including the Participant’s death or disability), then the Participant shall forfeit to the Company any shares acquired by the Participant pursuant to a Restricted Stock Award which remain subject to Vesting Conditions as of the
date of the Participant’s termination of Service. 
 8.5 Nontransferability of Restricted Stock Award Rights. Prior
to the issuance of shares of Stock pursuant to a Restricted Stock Award, rights to acquire such shares shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance or garnishment by
creditors of the Participant or the Participant’s beneficiary, except transfer by will or the laws of descent and distribution. All rights with respect to a Restricted Stock Award granted to a Participant hereunder shall be exercisable during
his or her lifetime only by such Participant or the Participant’s guardian or legal representative. 
  

	 	9.	TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT
AWARDS. 

 Restricted Stock Unit Awards shall be evidenced by Award
Agreements specifying the number of Restricted Stock Units subject to the Award, in such form as the Board shall from time to time establish. No Restricted Stock Unit Award or purported Restricted Stock Unit Award shall be a valid and binding
obligation of the Company unless evidenced by a fully executed Award Agreement. Award Agreements evidencing Restricted Stock Units may incorporate all or any of the terms of the Plan by reference and shall comply with and be subject to the following
terms and conditions: 
 9.1 Purchase Price. No monetary payment (other than applicable tax withholding, if any) shall be
required as a condition of receiving a Restricted Stock Unit Award, the consideration for which shall be services actually rendered to a Participating Company or for its benefit. 

  
 -12-

 9.2 Vesting. Restricted Stock Units may or may not be made subject to Vesting
Conditions based upon the satisfaction of such Service requirements, conditions, restrictions or performance criteria, as shall be established by the Board and set forth in the Award Agreement evidencing such Award. 

9.3 Voting Rights, Dividend Equivalent Rights and Distributions. Participants shall have no voting rights with respect to shares
of Stock represented by Restricted Stock Units until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company). However, the Board, in its
discretion, may provide in the Award Agreement evidencing any Restricted Stock Unit Award that the Participant shall be entitled to receive Dividend Equivalents with respect to the payment of cash dividends on Stock having a record date prior to
date on which Restricted Stock Units held by such Participant are settled. Such Dividend Equivalents, if any, shall be paid by crediting the Participant with additional whole Restricted Stock Units as of the date of payment of such cash dividends on
Stock. The number of additional Restricted Stock Units (rounded to the nearest whole number) to be so credited shall be determined by dividing (a) the amount of cash dividends paid on such date with respect to the number of shares of Stock
represented by the Restricted Stock Units previously credited to the Participant by (b) the Fair Market Value per share of Stock on such date. Such additional Restricted Stock Units shall be subject to the same terms and conditions and shall be
settled in the same manner and at the same time (or as soon thereafter as practicable) as the Restricted Stock Units originally subject to the Restricted Stock Unit Award. In the event of a dividend or distribution paid in shares of Stock or
any other adjustment made upon a change in the capital structure of the Company as described in Section 4.2, appropriate adjustments shall be made in the Participant’s Restricted Stock Unit Award so that it represents the right to receive
upon settlement any and all new, substituted or additional securities or other property (other than normal cash dividends) to which the Participant would be entitled by reason of the shares of Stock issuable upon settlement of the Award, and all
such new, substituted or additional securities or other property shall be immediately subject to the same Vesting Conditions as are applicable to the Award. 
 9.4 Effect of Termination of Service. Unless otherwise provided by the Board in the grant of a Restricted Stock Unit Award and set forth in the Award Agreement, if a Participant’s Service
terminates for any reason, whether voluntary or involuntary (including the Participant’s death or disability), then the Participant shall forfeit to the Company any Restricted Stock Units pursuant to the Award which remain subject to Vesting
Conditions as of the date of the Participant’s termination of Service. 
 9.5 Settlement of Restricted Stock Unit
Awards. The Company shall issue to a Participant on the date on which Restricted Stock Units subject to the Participant’s Restricted Stock Unit Award vest or on such other settlement date determined by the Board, in its discretion, and set
forth in the Award Agreement one (1) share of Stock (and/or any other new, substituted or additional securities or other property pursuant to an adjustment described in Section 9.3) for each Restricted

  
 -13-

 
Stock Unit then becoming vested or otherwise to be settled on such date, subject to the withholding of applicable taxes, if any. Notwithstanding the foregoing, if permitted by the Board and set
forth in the Award Agreement, the Participant may elect in accordance with terms specified in the Award Agreement to defer receipt of all or any portion of the shares of Stock or other property otherwise issuable to the Participant pursuant to this
Section. 
 9.6 Nontransferability of Restricted Stock Unit Awards. Prior to the issuance of shares of Stock in
settlement of a Restricted Stock Unit Award, the Award shall not be subject in any manner to anticipation, alienation, sale, exchange, transfer, assignment, pledge, encumbrance, or garnishment by creditors of the Participant or the
Participant’s beneficiary, except transfer by will or by the laws of descent and distribution. All rights with respect to a Restricted Stock Unit Award granted to a Participant hereunder shall be exercisable during his or her lifetime only by
such Participant or the Participant’s guardian or legal representative. 
 9.7 Automatic Grant of Restricted Stock Unit
Awards. Each Outside Director who first becomes an Outside Director prior to September 14, 2010 shall be granted automatically and without further action of the Board a Restricted Stock Unit Award covering 5,000 units on the date on which
such person first becomes an Outside Director, whether through election by the stockholders of the Company or appointment by the Board to fill a vacancy; provided, however, that an Inside Director who ceases to be an Inside Director but who remains
a Director shall not receive such a Restricted Stock Unit Award. The Restricted Stock Unit Award shall vest as to twenty-five percent of the units subject to the Restricted Stock Unit Award on the one (1) year anniversary of its grant date and
as to one-sixteenth (1/16) of the units originally subject to the Restricted Stock Unit Award each quarter thereafter, so as to be 100% vested on the four year anniversary of the grant date, provided that the Optionee continues to serve as an
Outside Director on such dates. The Board in its discretion may change and otherwise revise the terms of Restricted Stock Unit Awards granted under this Section 9.7, including, without limitation, the number of units subject thereto, for
Restricted Stock Unit Awards granted on or after the date the Board determines to make any such change or revision. 
  

	 	10.	STANDARD FORMS OF AWARD AGREEMENT. 

10.1 Award Agreement. Each Award shall comply with and be subject to the terms and conditions set forth in the appropriate form of
Award Agreement approved by the Board and as amended from time to time. Any Award Agreement may consist of an appropriate form of Notice of Grant and a form of Agreement incorporated therein by reference, or such other form or forms as the Board may
approve from time to time. 
 10.2 Authority to Vary Terms. The Board shall have the authority from time to time to vary
the terms of any standard form of Award Agreement either in connection with the grant or amendment of an individual Award or in connection with the authorization of a new standard form or forms; provided, however, that the terms and conditions of
any such new, revised or amended standard form or forms of Award Agreement are not inconsistent with the terms of the Plan. 

  
 -14-

	 	11.	CHANGE IN CONTROL. 

11.1 Definitions. 
 (a) An “Ownership Change Event” shall be deemed to have occurred if any of the following occurs with respect to the Company: (i) the direct or indirect sale or exchange in a
single or series of related transactions by the stockholders of the Company of more than fifty percent (50%) of the voting stock of the Company; (ii) a merger or consolidation in which the Company is a party; (iii) the sale, exchange,
or transfer of all or substantially all of the assets of the Company; or (iv) a liquidation or dissolution of the Company. 
 (b) A “Change in Control” shall mean an Ownership Change Event or a series of related Ownership Change Events (collectively, a “Transaction”) wherein the
stockholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially the same proportions as their ownership of shares of the Company’s voting stock immediately before the Transaction,
direct or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding voting securities of the Company or, in the case of a Transaction described in Section 11.1(a)(iii), the
corporation or other business entity to which the assets of the Company were transferred (the “Transferee”), as the case may be. For purposes of the preceding sentence, indirect beneficial ownership shall include, without
limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which own the Company or the Transferee, as the case may be, either directly or through one or more subsidiary
corporations or other business entities. The Board shall have the right to determine whether multiple sales or exchanges of the voting securities of the Company or multiple Ownership Change Events are related, and its determination shall be final,
binding and conclusive. 
 11.2 Effect of Change in Control on Options. 

(a) Accelerated Vesting. Notwithstanding any other provision of the Plan to the contrary, in the event of a Change in
Control, each Option held by a Participant whose Service has not terminated prior to the date of such Change in Control shall become immediately exercisable and vested in full as of such date, subject to the consummation of the Change in Control.

 (b) Assumption or Substitution. In the event of a Change in Control, the surviving, continuing, successor, or
purchasing entity or parent thereof, as the case may be (the “Acquiror”), may, without the consent of any Participant, either assume the Company’s rights and obligations under outstanding Options or substitute for
outstanding Options substantially equivalent options for the Acquiror’s stock. Any Options which are not assumed by the Acquiror in connection with the Change in Control nor exercised as of the time of consummation of the Change in Control
shall terminate and cease to be outstanding effective as of the time of consummation of the Change in Control. 

  
 -15-

 (c) Cash-Out of Options. The Board may, in its sole discretion and without
the consent of any Participant, determine that, upon the occurrence of a Change in Control, each or any Option outstanding immediately prior to the Change in Control shall be canceled in exchange for a payment with respect to each vested share of
Stock subject to such canceled Option in (i) cash, (ii) stock of the Company or of a corporation or other business entity a party to the Change in Control, or (iii) other property which, in any such case, shall be in an amount having
a Fair Market Value equal to the excess of the Fair Market Value of the consideration to be paid per share of Stock in the Change in Control over the exercise price per share under such Option (the “Spread”). In the event
such determination is made by the Board, the Spread (reduced by applicable withholding taxes, if any) shall be paid to Participants in respect of their canceled Options as soon as practicable following the date of the Change in Control. 

11.3 Effect of Change in Control on Restricted Stock Awards. The Board may, in its discretion, provide in any Award Agreement
evidencing a Restricted Stock Award that, in the event of a Change in Control, the lapsing of the Restriction Period applicable to the shares subject to the Restricted Stock Award held by a Participant whose Service has not terminated prior to such
date shall be accelerated effective immediately prior to the consummation of the Change in Control to such extent as specified in such Award Agreement. Any acceleration of the lapsing of the Restriction Period that was permissible solely by reason
of this Section 11.3 and the provisions of such Award Agreement shall be conditioned upon the consummation of the Change in Control. 
 11.4 Restricted Stock Unit Award Acceleration. Notwithstanding any other provision of the Plan to the contrary, in the event of a Change in Control, each Restricted Stock Unit Award held by a
Participant whose Service has not terminated prior to the date of such Change in Control shall become immediately vested in full as of such date, subject to the consummation of the Change in Control. 

 

	 	12.	COMPLIANCE WITH SECURITIES LAW. 

The grant of Awards and the issuance of shares of Stock pursuant to any Award shall be subject to compliance with all applicable
requirements of federal, state and foreign law with respect to such securities and the requirements of any stock exchange or market system upon which the Stock may then be listed. In addition, no Award may be exercised or shares issued pursuant to
an Award unless (i) a registration statement under the Securities Act shall at the time of such exercise or issuance be in effect with respect to the shares issuable pursuant to the Award or (ii) in the opinion of legal counsel to the
Company, the shares issuable pursuant to the Award may be issued in accordance with the terms of an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having
jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary to the lawful issuance and sale of any shares hereunder shall relieve the Company of any liability in respect of the failure to issue or sell such shares
as to which such requisite authority shall not have been obtained. As a condition to issuance of any Stock, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate, to evidence compliance with any
applicable law or regulation and to make any representation or warranty with respect thereto as may be requested by the Company. 

  
 -16-

	 	13.	TAX WITHHOLDING. 

 13.1 Tax Withholding in General. The Company shall have the right to deduct from any and all payments made under the Plan, or to require the Participant, through payroll withholding, cash payment
or otherwise, including by means of a Cashless Exercise of an Option, to make adequate provision for, the federal, state, local and foreign taxes, if any, required by law to be withheld by the Participating Company Group with respect to an Award or
the shares acquired pursuant thereto. The Company shall have no obligation to deliver shares of Stock, to release shares of Stock from an escrow established pursuant to an Award Agreement, or to make any payment in cash under the Plan until the
Participating Company Group’s tax withholding obligations have been satisfied by the Participant. 
 13.2 Withholding in
Shares. The Company shall have the right, but not the obligation, to deduct from the shares of Stock issuable to a Participant upon the exercise or settlement of an Award, or to accept from the Participant the tender of, a number of whole shares
of Stock having a Fair Market Value, as determined by the Company, equal to all or any part of the tax withholding obligations of the Participating Company Group. The Fair Market Value of any shares of Stock withheld or tendered to satisfy any such
tax withholding obligations shall not exceed the amount determined by the applicable minimum statutory withholding rates. 
  

	 	14.	AMENDMENT OR TERMINATION OF PLAN. 

The Board may amend, suspend or terminate the Plan at any time. However, without the approval of the Company’s stockholders, there
shall be (a) no increase in the maximum aggregate number of shares of Stock that may be issued under the Plan (except by operation of the provisions of Section 4.2) and (b) no other amendment of the Plan that would require approval of
the Company’s stockholders under any applicable law, regulation or rule. No amendment, suspension or termination of the Plan shall affect any then outstanding Award unless expressly provided by the Board. In any event, no amendment, suspension
or termination of the Plan may adversely affect any then outstanding Award without the consent of the Participant unless necessary to comply with any applicable law, regulation or rule. 

 

	 	15.	MISCELLANEOUS PROVISIONS. 

15.1 Repurchase Rights. Shares issued under the Plan may be subject to one or more repurchase options, or other conditions and
restrictions as determined by the Board in its discretion at the time the Award is granted. The Company shall have the right to assign at any time any repurchase right it may have, whether or not such right is then exercisable, to one or more
persons as may be selected by the Company. Upon request by the Company, each Participant shall execute any agreement evidencing such transfer restrictions prior to the receipt of shares of Stock hereunder and shall promptly present to the Company
any and all certificates representing shares of Stock acquired hereunder for the placement on such certificates of appropriate legends evidencing any such transfer restrictions. 

  
 -17-

 15.2 Provision of Information. Each Participant shall be given access to information
concerning the Company equivalent to that information generally made available to the Company’s common stockholders. 

15.3 Rights as Outside Director. No person, even though eligible pursuant to Section 5, shall have a right to be selected as
a Participant, or, having been so selected, to be selected again as a Participant. Nothing in the Plan or any Award granted under the Plan shall confer on any Participant a right to remain an Outside Director, or interfere with or limit in any way
any right of a Participating Company to terminate the Participant’s Service at any time. 
 15.4 Rights as a
Stockholder. A Participant shall have no rights as a stockholder with respect to any shares covered by an Award until the date of the issuance of such shares (as evidenced by the appropriate entry on the books of the Company or of a duly
authorized transfer agent of the Company). No adjustment shall be made for dividends, distributions or other rights for which the record date is prior to the date such shares are issued, except as provided in Section 4.2 or another provision of
the Plan. 
 15.5 Fractional Shares. The Company shall not be required to issue fractional shares upon the exercise or
settlement of any Award. 
 15.6 Severability. If any one or more of the provisions (or any part thereof) of this
Plan shall be held invalid, illegal or unenforceable in any respect, such provision shall be modified so as to make it valid, legal and enforceable, and the validity, legality and enforceability of the remaining provisions (or any part
thereof) of the Plan shall not in any way be affected or impaired thereby. 
 15.7 Beneficiary Designation. Subject
to local laws and procedures, each Participant may file with the Company a written designation of a beneficiary who is to receive any benefit under the Plan to which the Participant is entitled in the event of such Participant’s death before he
or she receives any or all of such benefit. Each designation will revoke all prior designations by the same Participant, shall be in a form prescribed by the Company, and will be effective only when filed by the Participant in writing with the
Company during the Participant’s lifetime. If a married Participant designates a beneficiary other than the Participant’s spouse, the effectiveness of such designation may be subject to the consent of the Participant’s spouse. If a
Participant dies without an effective designation of a beneficiary who is living at the time of the Participant’s death, the Company will pay any remaining unpaid benefits to the Participant’s legal representative. 

15.8 Unfunded Obligation. Participants shall have the status of general unsecured creditors of the Company. Any amounts payable to
Participants pursuant to the Plan shall be unfunded and unsecured obligations for all purposes, including, without limitation, Title I of the Employee Retirement Income Security Act of 1974. No Participating Company shall be required to segregate
any monies from its general funds, or to create any trusts, or establish any special accounts with respect to such obligations. The Company shall retain at all times beneficial ownership of any investments, including trust investments, which the
Company may make to fulfill its payment 

  
 -18-

 
obligations hereunder. Any investments or the creation or maintenance of any trust or any Participant account shall not create or constitute a trust or fiduciary relationship between the Board or
any Participating Company and a Participant, or otherwise create any vested or beneficial interest in any Participant or the Participant’s creditors in any assets of any Participating Company. The Participants shall have no claim against any
Participating Company for any changes in the value of any assets which may be invested or reinvested by the Company with respect to the Plan. 

  
 -19-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00186-of-00352.parquet"}]]